<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37445634</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>17</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>13</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>21</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights into Epidemiology, Pathogenesis, Therapeutic Perspectives and Challenges.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">10458</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms241310458</ELocationID><Abstract><AbstractText>Long COVID (LC) encompasses a constellation of long-term symptoms experienced by at least 10% of people after the initial SARS-CoV-2 infection, and so far it has affected about 65 million people. The etiology of LC remains unclear; however, many pathophysiological pathways may be involved, including viral persistence; a chronic, low-grade inflammatory response; immune dysregulation and a defective immune response; the reactivation of latent viruses; autoimmunity; persistent endothelial dysfunction and coagulopathy; gut dysbiosis; hormonal and metabolic dysregulation; mitochondrial dysfunction; and autonomic nervous system dysfunction. There are no specific tests for the diagnosis of LC, and clinical features including laboratory findings and biomarkers may not specifically relate to LC. Therefore, it is of paramount importance to develop and validate biomarkers that can be employed for the prediction, diagnosis and prognosis of LC and its therapeutic response, although this effort may be hampered by challenges pertaining to the non-specific nature of the majority of clinical manifestations in the LC spectrum, small sample sizes of relevant studies and other methodological issues. Promising candidate biomarkers that are found in some patients are markers of systemic inflammation, including acute phase proteins, cytokines and chemokines; biomarkers reflecting SARS-CoV-2 persistence, the reactivation of herpesviruses and immune dysregulation; biomarkers of endotheliopathy, coagulation and fibrinolysis; microbiota alterations; diverse proteins and metabolites; hormonal and metabolic biomarkers; and cerebrospinal fluid biomarkers. At present, there are only two reviews summarizing relevant biomarkers; however, they do not cover the entire umbrella of current biomarkers, their link to etiopathogenetic mechanisms or the diagnostic work-up in a comprehensive manner. Herein, we aim to appraise and synopsize the available evidence on the typical laboratory manifestations and candidate biomarkers of LC, their classification based on pathogenetic mechanisms and the main LC symptomatology in the frame of the epidemiological and clinical aspects of the syndrome and furthermore assess limitations and challenges as well as potential implications in candidate therapeutic interventions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tsilingiris</LastName><ForeName>Dimitrios</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-6864-4289</Identifier><AffiliationInfo><Affiliation>First Department of Internal Medicine, University Hospital of Alexandroupolis, Democritus University of Thrace, Dragana, 68100 Alexandroupolis, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vallianou</LastName><ForeName>Natalia G</ForeName><Initials>NG</Initials><Identifier Source="ORCID">0000-0003-3874-5393</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Evangelismos General Hospital, 45-47 Ipsilantou Street, 10676 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karampela</LastName><ForeName>Irene</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0001-6912-4042</Identifier><AffiliationInfo><Affiliation>2nd Department of Critical Care, Medical School, University of Athens, Attikon General University Hospital, 1 Rimini Street, 12462 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Christodoulatos</LastName><ForeName>Gerasimos Socrates</ForeName><Initials>GS</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Sismanogleio General Hospital, 1 Sismanogleiou Street, 15126 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papavasileiou</LastName><ForeName>Georgios</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-1115-2782</Identifier><AffiliationInfo><Affiliation>Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 75 Mikras Asias Street, 11527 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petropoulou</LastName><ForeName>Dimitra</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 75 Mikras Asias Street, 11527 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magkos</LastName><ForeName>Faidon</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-1312-7364</Identifier><AffiliationInfo><Affiliation>Department of Nutrition, Exercise, and Sports, University of Copenhagen, DK-2200 Frederiksberg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dalamaga</LastName><ForeName>Maria</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-7008-388X</Identifier><AffiliationInfo><Affiliation>Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 75 Mikras Asias Street, 11527 Athens, Greece.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000209">Acute-Phase Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000209" MajorTopicYN="N">Acute-Phase Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">biomarkers</Keyword><Keyword MajorTopicYN="N">epidemiology</Keyword><Keyword MajorTopicYN="N">laboratory</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">pathogenesis</Keyword><Keyword MajorTopicYN="N">post-COVID</Keyword><Keyword MajorTopicYN="N">post-COVID syndrome (PCS)</Keyword><Keyword MajorTopicYN="N">post-acute sequelae of SARS-CoV infection (PASC)</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>6</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>14</Day><Hour>13</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>14</Day><Hour>1</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37445634</ArticleId><ArticleId IdType="pmc">PMC10341908</ArticleId><ArticleId IdType="doi">10.3390/ijms241310458</ArticleId><ArticleId IdType="pii">ijms241310458</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO  Coronavirus (COVID-19) Dashboard.  [(accessed on 7 June 2023)].  Available online:  https://covid19.who.int/</Citation></Reference><Reference><Citation>Lee W.E., Woo Park S., Weinberger D.M., Olson D., Simonsen L., Grenfell B.T., Viboud C. Direct and indirect mortality impacts of the COVID-19 pandemic in the United States, 1 March 2020 to 1 January 2022. Elife. 2023;12:e77562. doi: 10.7554/eLife.77562.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.77562</ArticleId><ArticleId IdType="pmc">PMC9946455</ArticleId><ArticleId IdType="pubmed">36811598</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicola M., Alsafi Z., Sohrabi C., Kerwan A., Al-Jabir A., Iosifidis C., Agha M., Agha R. The socio-economic implications of the coronavirus pandemic (COVID-19): A review. Int. J. Surg. 2020;78:185&#x2013;193. doi: 10.1016/j.ijsu.2020.04.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijsu.2020.04.018</ArticleId><ArticleId IdType="pmc">PMC7162753</ArticleId><ArticleId IdType="pubmed">32305533</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsilingiris D., Vallianou N.G., Karampela I., Liu J., Dalamaga M. Potential implications of lipid nanoparticles in the pathogenesis of myocarditis associated with the use of mRNA vaccines against SARS-CoV-2. Metab. Open. 2022;13:100159. doi: 10.1016/j.metop.2021.100159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metop.2021.100159</ArticleId><ArticleId IdType="pmc">PMC8677426</ArticleId><ArticleId IdType="pubmed">34938983</ArticleId></ArticleIdList></Reference><Reference><Citation>Marzian&#x3bf; V., Guzzetta G., Menegale F., Sacco C., Petrone D., Urdiales A., del Manso M., Bella A., Fabiani M., Vescio M., et al. The decline of COVID-19 severity and lethality over two years of pandemic. Res. Sq. 2022 doi: 10.21203/rs.3.rs-1784587/v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-1784587/v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigal A. Milder disease with Omicron: Is it the virus or the pre-existing immunity? Nat. Rev. Immunol. 2022;22:69&#x2013;71. doi: 10.1038/s41577-022-00678-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-022-00678-4</ArticleId><ArticleId IdType="pmc">PMC8767774</ArticleId><ArticleId IdType="pubmed">35046570</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahase E. COVID-19: What do we know about XBB.1.5 and should we be worried? BMJ. 2023;380:153. doi: 10.1136/bmj.p153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.p153</ArticleId><ArticleId IdType="pubmed">36657748</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO  XBB.1.5 Updated Risk Assessment, 24 February 2023.  [(accessed on 15 May 2023)].  Available online:  https://www.who.int/docs/default-source/coronaviruse/22022024xbb.1.5ra.pdf.</Citation></Reference><Reference><Citation>Siddiqui S., Alhamdi H.W.S., Alghamdi H.A. Recent Chronology of COVID-19 Pandemic. Front. Public Health. 2022;10:778037. doi: 10.3389/fpubh.2022.778037.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.778037</ArticleId><ArticleId IdType="pmc">PMC9114873</ArticleId><ArticleId IdType="pubmed">35602161</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xed;&#x161;ka D., Liptakov&#xe1; E., Babi&#x10d;ov&#xe1; A., Batalik L., Ba&#x148;&#xe1;rov&#xe1; P.S., Dobrodenkov&#xe1; S. What is the quality of life in patients with long COVID compared to a healthy control group? Front. Public Health. 2022;10:975992. doi: 10.3389/fpubh.2022.975992.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.975992</ArticleId><ArticleId IdType="pmc">PMC9667067</ArticleId><ArticleId IdType="pubmed">36408018</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO: Post COVID-19 Condition (Long COVID)  [(accessed on 6 June 2023)].  Available online:  https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition#:~:text=It%20is%20defined%20as%20the,months%20with%20no%20other%20explanation.</Citation></Reference><Reference><Citation>NICE: COVID-19 Rapid Guideline: Managing the Longterm Effects of COVID-19.  [(accessed on 6 June 2023)].  Available online:  https://www.nice.org.uk/guidance/ng188/resources/covid19-rapid-guideline-managing-the-longterm-effects-of-covid19-pdf-51035515742#:~:text=In%20addition%20to%20the%20clinical,)%20and%20post%E2%80%91COVID%E2%80%9119.</Citation></Reference><Reference><Citation>CDC: Long COVID or Post-COVID Conditions.  [(accessed on 6 June 2023)]; Available online:  https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html#:~:text=Long%20COVID%20is%20broadly%20defined,with%20CDC%20and%20other%20partners.</Citation></Reference><Reference><Citation>Robert Koch Institute: RKI Information Portal on Long COVID.  [(accessed on 6 June 2023)].  Available online:  https://www.rki.de/EN/Content/infections/epidemiology/outbreaks/COVID-19/Long-COVID/content-total.html.</Citation></Reference><Reference><Citation>Government of Canada: Post COVID-19 Condition (Long COVID)  [(accessed on 6 June 2023)]; Available online:  https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection/symptoms/post-covid-19-condition.html.</Citation></Reference><Reference><Citation>Jennings G., Monaghan A., Xue F., Mockler D., Romero-Ortu&#xf1;o R. A Systematic Review of Persistent Symptoms and Residual Abnormal Functioning following Acute COVID-19: Ongoing Symptomatic Phase vs. Post-COVID-19 Syndrome. J. Clin. Med. 2021;10:5913. doi: 10.3390/jcm10245913.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10245913</ArticleId><ArticleId IdType="pmc">PMC8708187</ArticleId><ArticleId IdType="pubmed">34945213</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO: Expanding Our Understanding of Post COVID-19 Condition  Report of a WHO Webinar, 9 February 2021.  [(accessed on 6 June 2023)].  Available online:  https://www.who.int/publications/i/item/9789240025035.</Citation></Reference><Reference><Citation>Roe K. The Symptoms and Clinical Manifestations Observed in COVID-19 Patients/Long COVID-19 Symptoms that Parallel Toxoplasma gondii Infections. J. Neuroimmune Pharmacol. 2021;16:513&#x2013;516. doi: 10.1007/s11481-021-09997-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-021-09997-0</ArticleId><ArticleId IdType="pmc">PMC8163588</ArticleId><ArticleId IdType="pubmed">34050501</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., Villapol S. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Sci. Rep. 2021;11:16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanares-Zapatero D., Chalon P., Kohn L., Dauvrin M., Detollenaere J., Maertens de Noordhout C., Primus-de Jong C., Cleemput I., Van den Heede K. Pathophysiology and mechanism of long COVID: A comprehensive review. Ann. Med. 2022;54:1473&#x2013;1487. doi: 10.1080/07853890.2022.2076901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2022.2076901</ArticleId><ArticleId IdType="pmc">PMC9132392</ArticleId><ArticleId IdType="pubmed">35594336</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalamaga M., Karmaniolas K., Matekovits A., Migdalis I., Papadavid E. Cutaneous manifestations in relation to immunologic parameters in a cohort of primary myelodysplastic syndrome patients. J. Eur. Acad. Dermatol. Venereol. 2008;22:543&#x2013;548. doi: 10.1111/j.1468-3083.2007.02520.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-3083.2007.02520.x</ArticleId><ArticleId IdType="pubmed">18070024</ArticleId></ArticleIdList></Reference><Reference><Citation>Mentis A.A., Dalamaga M., Lu C., Polissiou M.G. Saffron for &#x201c;toning down&#x201d; COVID-19-related cytokine storm: Hype or hope? A mini-review of current evidence. Metab. Open. 2021;11:100111. doi: 10.1016/j.metop.2021.100111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metop.2021.100111</ArticleId><ArticleId IdType="pmc">PMC8294713</ArticleId><ArticleId IdType="pubmed">34312610</ArticleId></ArticleIdList></Reference><Reference><Citation>Varghese J., Sandmann S., Ochs K., Schrempf I.M., Fr&#xf6;mmel C., Dugas M., Schmidt H.H., Vollenberg R., Tepasse P.R. Persistent symptoms and lab abnormalities in patients who recovered from COVID-19. Sci. Rep. 2021;11:12775. doi: 10.1038/s41598-021-91270-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-91270-8</ArticleId><ArticleId IdType="pmc">PMC8211641</ArticleId><ArticleId IdType="pubmed">34140539</ArticleId></ArticleIdList></Reference><Reference><Citation>Esp&#xed;n E., Yang C., Shannon C.P., Assadian S., He D., Tebbutt S.J. Cellular and molecular biomarkers of long COVID: A scoping review. EBioMedicine. 2023;91:104552. doi: 10.1016/j.ebiom.2023.104552.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2023.104552</ArticleId><ArticleId IdType="pmc">PMC10082390</ArticleId><ArticleId IdType="pubmed">37037165</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai Y.J., Liu S.H., Manachevakul S., Lee T.A., Kuo C.T., Bello D. Biomarkers in long COVID-19: A systematic review. Front. Med. 2023;10:1085988. doi: 10.3389/fmed.2023.1085988.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1085988</ArticleId><ArticleId IdType="pmc">PMC9895110</ArticleId><ArticleId IdType="pubmed">36744129</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie T., Hittle M., Goodman S.N. Assessment of the Frequency and Variety of Persistent Symptoms among Patients with COVID-19: A Systematic Review. JAMA Netw. Open. 2021;4:e2111417. doi: 10.1001/jamanetworkopen.2021.11417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.11417</ArticleId><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizrahi B., Sudry T., Flaks-Manov N., Yehezkelli Y., Kalkstein N., Akiva P., Ekka-Zohar A., Ben David S.S., Lerner U., Bivas-Benita M., et al. Long COVID outcomes at one year after mild SARS-CoV-2 infection: Nationwide cohort study. BMJ. 2023;380:e072529. doi: 10.1136/bmj-2022-072529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-072529</ArticleId><ArticleId IdType="pmc">PMC9832503</ArticleId><ArticleId IdType="pubmed">36631153</ArticleId></ArticleIdList></Reference><Reference><Citation>UK Office for National Statistics  Prevalence of Ongoing Symptoms Following Coronavirus (COVID-19) Infection in the UK.  [(accessed on 17 May 2023)]; Available online:  https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/datasets/alldatarelatingtoprevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk.</Citation></Reference><Reference><Citation>Ahmad F.B., Anderson R.N., Cisewski J.A., Sutton P.D. Identification of Deaths with Post-Acute Sequelae of COVID-19 from death Certificate Literal Text: United States, 1 January 2020&#x2013;30 June 2022. CDC; Atlanta, GA, USA: 2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.15620/cdc:121968</ArticleId></ArticleIdList></Reference><Reference><Citation>Du M., Ma Y., Deng J., Liu M., Liu J. Comparison of Long COVID-19 Caused by Different SARS-CoV-2 Strains: A Systematic Review and Meta-Analysis. Int. J. Environ. Res. Public Health. 2022;19:16010. doi: 10.3390/ijerph192316010.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph192316010</ArticleId><ArticleId IdType="pmc">PMC9736973</ArticleId><ArticleId IdType="pubmed">36498103</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M., Pujol J.C., Spector T.D., Ourselin S., Steves C.J. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. 2022;399:2263&#x2013;2264. doi: 10.1016/S0140-6736(22)00941-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00941-2</ArticleId><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehme M., Vetter P., Chappuis F., Kaiser L., Guessous I. Prevalence of Post-Coronavirus Disease Condition 12 Weeks after Omicron Infection Compared with Negative Controls and Association with Vaccination Status. Clin. Infect. Dis. 2023;76:1567&#x2013;1575. doi: 10.1093/cid/ciac947.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac947</ArticleId><ArticleId IdType="pubmed">36519381</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballouz T., Menges D., Kaufmann M., Amati R., Frei A., von Wyl V., Fehr J.S., Albanese E., Puhan M.A. Post COVID-19 condition after Wildtype, Delta, and Omicron SARS-CoV-2 infection and prior vaccination: Pooled analysis of two population-based cohorts. PLoS ONE. 2023;18:e0281429. doi: 10.1371/journal.pone.0281429.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0281429</ArticleId><ArticleId IdType="pmc">PMC9946205</ArticleId><ArticleId IdType="pubmed">36812215</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy N., Koppel J.H., Kaplan O., Yechiam H., Shahar-Nissan K., Cohen N.K., Shavit I. Severity and Incidence of Multisystem Inflammatory Syndrome in Children during 3 SARS-CoV-2 Pandemic Waves in Israel. JAMA. 2022;327:2452&#x2013;2454. doi: 10.1001/jama.2022.8025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.8025</ArticleId><ArticleId IdType="pmc">PMC9121298</ArticleId><ArticleId IdType="pubmed">35588048</ArticleId></ArticleIdList></Reference><Reference><Citation>Amanatidou E., Gkiouliava A., Pella E., Serafidi M., Tsilingiris D., Vallianou N.G., Karampela I., Dalamaga M. Breakthrough infections after COVID-19 vaccination: Insights, perspectives and challenges. Metab. Open. 2022;14:100180. doi: 10.1016/j.metop.2022.100180.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metop.2022.100180</ArticleId><ArticleId IdType="pmc">PMC8928742</ArticleId><ArticleId IdType="pubmed">35313532</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalamaga M., Nasiri-Ansari N., Spyrou N. Perspectives and Challenges of COVID-19 with Obesity-Related Cancers. Cancers. 2023;15:1771. doi: 10.3390/cancers15061771.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers15061771</ArticleId><ArticleId IdType="pmc">PMC10046880</ArticleId><ArticleId IdType="pubmed">36980657</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsilingiris D., Nasiri-Ansari N., Spyrou N., Magkos F., Dalamaga M. Management of Hematologic Malignancies in the Era of COVID-19 Pandemic: Pathogenetic Mechanisms, Impact of Obesity, Perspectives, and Challenges. Cancers. 2022;14:2494. doi: 10.3390/cancers14102494.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers14102494</ArticleId><ArticleId IdType="pmc">PMC9139192</ArticleId><ArticleId IdType="pubmed">35626099</ArticleId></ArticleIdList></Reference><Reference><Citation>Syriga M., Karampela I., Dalamaga M., Karampelas M. The effect of COVID-19 pandemic on the attendance and clinical outcomes of patients with ophthalmic disease: A mini-review. Metab. Open. 2021;12:100131. doi: 10.1016/j.metop.2021.100131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metop.2021.100131</ArticleId><ArticleId IdType="pmc">PMC8474871</ArticleId><ArticleId IdType="pubmed">34604730</ArticleId></ArticleIdList></Reference><Reference><Citation>Kikkenborg Berg S., Palm P., Nygaard U., Bundgaard H., Petersen M.N.S., Rosenkilde S., Thorsted A.B., Ersb&#xf8;ll A.K., Thygesen L.C., Nielsen S.D., et al. Long COVID symptoms in SARS-CoV-2-positive children aged 0-14 years and matched controls in Denmark (LongCOVIDKidsDK): A national, cross-sectional study. Lancet. Child Adolesc. Health. 2022;6:614&#x2013;623. doi: 10.1016/S2352-4642(22)00154-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(22)00154-7</ArticleId><ArticleId IdType="pmc">PMC9221683</ArticleId><ArticleId IdType="pubmed">35752194</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xf8;rensen A.I.V., Spiliopoulos L., Bager P., Nielsen N.M., Hansen J.V., Koch A., Meder I.K., Ethelberg S., Hviid A. A nationwide questionnaire study of post-acute symptoms and health problems after SARS-CoV-2 infection in Denmark. Nat. Commun. 2022;13:4213. doi: 10.1038/s41467-022-31897-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-31897-x</ArticleId><ArticleId IdType="pmc">PMC9302226</ArticleId><ArticleId IdType="pubmed">35864108</ArticleId></ArticleIdList></Reference><Reference><Citation>Roessler M., Tesch F., Batram M., Jacob J., Loser F., Weidinger O., Wende D., Vivirito A., Toepfner N., Ehm F., et al. Post-COVID-19-associated morbidity in children, adolescents, and adults: A matched cohort study including more than 157,000 individuals with COVID-19 in Germany. PLoS Med. 2022;19:e1004122. doi: 10.1371/journal.pmed.1004122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1004122</ArticleId><ArticleId IdType="pmc">PMC9648706</ArticleId><ArticleId IdType="pubmed">36355754</ArticleId></ArticleIdList></Reference><Reference><Citation>Edlow A.G., Castro V.M., Shook L.L., Kaimal A.J., Perlis R.H. Neurodevelopmental Outcomes at 1 Year in Infants of Mothers Who Tested Positive for SARS-CoV-2 during Pregnancy. JAMA Netw. Open. 2022;5:e2215787. doi: 10.1001/jamanetworkopen.2022.15787.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.15787</ArticleId><ArticleId IdType="pmc">PMC9185175</ArticleId><ArticleId IdType="pubmed">35679048</ArticleId></ArticleIdList></Reference><Reference><Citation>Vella L.A., Rowley A.H. Current Insights Into the Pathophysiology of Multisystem Inflammatory Syndrome in Children. Curr. Pediatr. Rep. 2021;9:83&#x2013;92. doi: 10.1007/s40124-021-00257-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40124-021-00257-6</ArticleId><ArticleId IdType="pmc">PMC8524214</ArticleId><ArticleId IdType="pubmed">34692237</ArticleId></ArticleIdList></Reference><Reference><Citation>Melgar M., Lee E.H., Miller A.D., Lim S., Brown C.M., Yousaf A.R., Zambrano L.D., Belay E.D., Godfred-Cato S., Abrams J.Y., et al. Council of State and Territorial Epidemiologists/CDC Surveillance Case Definition for Multisystem Inflammatory Syndrome in Children Associated with SARS-CoV-2 Infection&#x2014;United States. MMWR. Recomm. Rep. 2022;71:1&#x2013;14. doi: 10.15585/mmwr.rr7104a1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.rr7104a1</ArticleId><ArticleId IdType="pmc">PMC9762894</ArticleId><ArticleId IdType="pubmed">36520808</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsampasian V., Elghazaly H., Chattopadhyay R., Debski M., Naing T.K.P., Garg P., Clark A., Ntatsaki E., Vassiliou V.S. Risk Factors Associated with Post-COVID-19 Condition: A Systematic Review and Meta-analysis. JAMA Intern. Med. 2023;183:566&#x2013;580. doi: 10.1001/jamainternmed.2023.0750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2023.0750</ArticleId><ArticleId IdType="pmc">PMC10037203</ArticleId><ArticleId IdType="pubmed">36951832</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya A.A., Akbari A., Emami A., Lotfi M., Rostamihosseinkhani M., Nemati H., Barzegar Z., Kabiri M., Zeraatpisheh Z., Farjoud-Kouhanjani M., et al. Risk Factors Associated with Long COVID Syndrome: A Retrospective Study. Iran. J. Med. Sci. 2021;46:428&#x2013;436. doi: 10.30476/ijms.2021.92080.2326.</Citation><ArticleIdList><ArticleId IdType="doi">10.30476/ijms.2021.92080.2326</ArticleId><ArticleId IdType="pmc">PMC8611223</ArticleId><ArticleId IdType="pubmed">34840383</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A., Nirantharakumar K., Hughes S., Myles P., Williams T., Gokhale K.M., Taverner T., Chandan J.S., Brown K., Simms-Williams N., et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat. Med. 2022;28:1706&#x2013;1714. doi: 10.1038/s41591-022-01909-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao S., Lee G.M., Razzaghi H., Lorman V., Mejias A., Pajor N.M., Thacker D., Webb R., Dickinson K., Bailey L.C., et al. Clinical Features and Burden of Postacute Sequelae of SARS-CoV-2 Infection in Children and Adolescents. JAMA Pediatr. 2022;176:1000&#x2013;1009. doi: 10.1001/jamapediatrics.2022.2800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2022.2800</ArticleId><ArticleId IdType="pmc">PMC9396470</ArticleId><ArticleId IdType="pubmed">35994282</ArticleId></ArticleIdList></Reference><Reference><Citation>Morello R., Mariani F., Mastrantoni L., De Rose C., Zampino G., Munblit D., Sigfrid L., Valentini P., Buonsenso D. Risk factors for post-COVID-19 condition (Long COVID) in children: A prospective cohort study. EClinicalMedicine. 2023;59:101961. doi: 10.1016/j.eclinm.2023.101961.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2023.101961</ArticleId><ArticleId IdType="pmc">PMC10101848</ArticleId><ArticleId IdType="pubmed">37073325</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Z., Ekstr&#xf6;m S., Bellander T., Ljungman P., Pershagen G., Eneroth K., Kull I., Bergstr&#xf6;m A., Georgelis A., Stafoggia M., et al. Ambient air pollution exposure linked to long COVID among young adults: A nested survey in a population-based cohort in Sweden. Lancet Reg. Health. Eur. 2023;28:100608. doi: 10.1016/j.lanepe.2023.100608.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2023.100608</ArticleId><ArticleId IdType="pmc">PMC9989696</ArticleId><ArticleId IdType="pubmed">37131862</ArticleId></ArticleIdList></Reference><Reference><Citation>Merzon E., Weiss M., Krone B., Cohen S., Ilani G., Vinker S., Cohen-Golan A., Green I., Israel A., Schneider T., et al. Clinical and Socio-Demographic Variables Associated with the Diagnosis of Long COVID Syndrome in Youth: A Population-Based Study. Int. J. Environ. Res. Public Health. 2022;19:5993. doi: 10.3390/ijerph19105993.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19105993</ArticleId><ArticleId IdType="pmc">PMC9141083</ArticleId><ArticleId IdType="pubmed">35627530</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D., Bosworth M.L., King S., Pouwels K.B., Glickman M., Nafilyan V., Zaccardi F., Khunti K., Alwan N.A., Walker A.S. Risk of Long COVID in People Infected with Severe Acute Respiratory Syndrome Coronavirus 2 After 2 Doses of a Coronavirus Disease 2019 Vaccine: Community-Based, Matched Cohort Study. Open Forum Infect. Dis. 2022;9:ofac464. doi: 10.1093/ofid/ofac464.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac464</ArticleId><ArticleId IdType="pmc">PMC9494414</ArticleId><ArticleId IdType="pubmed">36168555</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., Bowe B., Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat. Med. 2022;28:1461&#x2013;1467. doi: 10.1038/s41591-022-01840-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Antar A.A.R., Yu T., Demko Z.O., Hu C., Tornheim J.A., Blair P.W., Thomas D.L., Manabe Y.C. Long COVID brain fog and muscle pain are associated with longer time to clearance of SARS-CoV-2 RNA from the upper respiratory tract during acute infection. medRxiv. 2023 doi: 10.3389/fimmu.2023.1147549.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1147549</ArticleId><ArticleId IdType="pmc">PMC10176965</ArticleId><ArticleId IdType="pubmed">37187756</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuchida T., Hirose M., Inoue Y., Kunishima H., Otsubo T., Matsuda T. Relationship between changes in symptoms and antibody titers after a single vaccination in patients with Long COVID. J. Med. Virol. 2022;94:3416&#x2013;3420. doi: 10.1002/jmv.27689.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27689</ArticleId><ArticleId IdType="pmc">PMC9088489</ArticleId><ArticleId IdType="pubmed">35238053</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen N.N., Nguyen Y.N., Hoang V.T., Million M., Gautret P. SARS-CoV-2 Reinfection and Severity of the Disease: A Systematic Review and Meta-Analysis. Viruses. 2023;15:967. doi: 10.3390/v15040967.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15040967</ArticleId><ArticleId IdType="pmc">PMC10145185</ArticleId><ArticleId IdType="pubmed">37112949</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B., Xie Y., Al-Aly Z. Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nat. Med. 2022;28:2398&#x2013;2405. doi: 10.1038/s41591-022-02051-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02051-3</ArticleId><ArticleId IdType="pmc">PMC9671810</ArticleId><ArticleId IdType="pubmed">36357676</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C., Haupert S.R., Zimmermann L., Shi X., Fritsche L.G., Mukherjee B. Global Prevalence of Post-Coronavirus Disease 2019 (COVID-19) Condition or Long COVID: A Meta-Analysis and Systematic Review. J. Infect. Dis. 2022;226:1593&#x2013;1607. doi: 10.1093/infdis/jiac136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Izquierdo-Pujol J., Moron-Lopez S., Dalmau J., Gonzalez-Aumatell A., Carreras-Abad C., Mendez M., Rodrigo C., Martinez-Picado J. Post COVID-19 Condition in Children and Adolescents: An Emerging Problem. Front. Pediatr. 2022;10:894204. doi: 10.3389/fped.2022.894204.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2022.894204</ArticleId><ArticleId IdType="pmc">PMC9130634</ArticleId><ArticleId IdType="pubmed">35633949</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Aumatell A., Bovo M.V., Carreras-Abad C., Cuso-Perez S., Dom&#xe8;nech Marsal &#xc8;., Coll-Fern&#xe1;ndez R., Goicoechea Calvo A., Giralt-L&#xf3;pez M., Ense&#xf1;at Cantallops A., Moron-Lopez S., et al. Social, Academic, and Health Status Impact of Long COVID on Children and Young People: An Observational, Descriptive, and Longitudinal Cohort Study. Children. 2022;9:1677. doi: 10.3390/children9111677.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/children9111677</ArticleId><ArticleId IdType="pmc">PMC9689050</ArticleId><ArticleId IdType="pubmed">36360405</ArticleId></ArticleIdList></Reference><Reference><Citation>Fonseca A., Lima R., Ladeira I., Guimar&#xe3;es M. Evaluation of pulmonary function in post-COVID-19 patients&#x2014;When and how should we do it? J. Bras. De Pneumol. 2021;47:e20210065. doi: 10.36416/1806-3756/e20210065.</Citation><ArticleIdList><ArticleId IdType="doi">10.36416/1806-3756/e20210065</ArticleId><ArticleId IdType="pmc">PMC8332721</ArticleId><ArticleId IdType="pubmed">34076176</ArticleId></ArticleIdList></Reference><Reference><Citation>Fortini A., Rosso A., Cecchini P., Torrigiani A., Lo Forte A., Carrai P., Alessi C., Fabbrizzi F., Lovicu E., Sbaragli S., et al. One-year evolution of DLCO changes and respiratory symptoms in patients with post COVID-19 respiratory syndrome. Infection. 2022;50:513&#x2013;517. doi: 10.1007/s15010-022-01755-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-022-01755-5</ArticleId><ArticleId IdType="pmc">PMC8777423</ArticleId><ArticleId IdType="pubmed">35061232</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanne J.P., Little B.P., Schulte J.J., Haramati A., Haramati L.B. Long-term Lung Abnormalities Associated with COVID-19 Pneumonia. Radiology. 2023;306:e221806. doi: 10.1148/radiol.221806.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.221806</ArticleId><ArticleId IdType="pmc">PMC9462591</ArticleId><ArticleId IdType="pubmed">36040336</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M., Manoharan L., Elkheir N., Cheng V., Dagens A., Hastie C., O&#x2019;Hara M., Suett J., Dahmash D., Bugaeva P., et al. Characterising long COVID: A living systematic review. BMJ Glob. Health. 2021;6:e005427. doi: 10.1136/bmjgh-2021-005427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Canas L.S., Molteni E., Deng J., Sudre C.H., Murray B., Kerfoot E., Antonelli M., Chen L., Rjoob K., Pujol J.C., et al. Profiling post-COVID syndrome across different variants of SARS-CoV-2. medRxiv. 2022 doi: 10.1101/2022.07.28.22278159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.07.28.22278159</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A., Cuthbertson D.J., Wootton D., Crooks M., Gabbay M., Eichert N., Mouchti S., Pansini M., Roca-Fernandez A., Thomaides-Brears H., et al. Multi-organ impairment and long COVID: A 1-year prospective, longitudinal cohort study. J. R. Soc. Med. 2023;116:97&#x2013;112. doi: 10.1177/01410768231154703.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768231154703</ArticleId><ArticleId IdType="pmc">PMC10041626</ArticleId><ArticleId IdType="pubmed">36787802</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedorowski A., Sutton R. Autonomic dysfunction and postural orthostatic tachycardia syndrome in post-acute COVID-19 syndrome. Nat. Rev. Cardiol. 2023;20:281&#x2013;282. doi: 10.1038/s41569-023-00842-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-023-00842-w</ArticleId><ArticleId IdType="pmc">PMC9893964</ArticleId><ArticleId IdType="pubmed">36732397</ArticleId></ArticleIdList></Reference><Reference><Citation>Espinosa-Gonzalez A.B., Master H., Gall N., Halpin S., Rogers N., Greenhalgh T. Orthostatic tachycardia after COVID-19. BMJ. 2023;380:e073488. doi: 10.1136/bmj-2022-073488.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-073488</ArticleId><ArticleId IdType="pubmed">36828559</ArticleId></ArticleIdList></Reference><Reference><Citation>Agashe S., Petak S. Cardiac Autonomic Neuropathy in Diabetes Mellitus. Methodist DeBakey Cardiovasc. J. 2018;14:251&#x2013;256. doi: 10.14797/mdcj-14-4-251.</Citation><ArticleIdList><ArticleId IdType="doi">10.14797/mdcj-14-4-251</ArticleId><ArticleId IdType="pmc">PMC6369622</ArticleId><ArticleId IdType="pubmed">30788010</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo B., Zhao C., He M.Z., Senter C., Zhou Z., Peng J., Li S., Fitzpatrick A.L., Lindstr&#xf6;m S., Stebbins R.C., et al. Long-term cardiac symptoms following COVID-19: A systematic review and meta-analysis. medRxiv. 2023 doi: 10.1101/2023.01.16.23284620.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.01.16.23284620</ArticleId><ArticleId IdType="pmc">PMC10685580</ArticleId><ArticleId IdType="pubmed">38017426</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Xu E., Bowe B., Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat. Med. 2022;28:583&#x2013;590. doi: 10.1038/s41591-022-01689-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Harding J.L., Oviedo S.A., Ali M.K., Ofotokun I., Gander J.C., Patel S.A., Magliano D.J., Patzer R.E. The bidirectional association between diabetes and long-COVID-19&#x2014;A systematic review. Diabetes Res. Clin. Pract. 2023;195:110202. doi: 10.1016/j.diabres.2022.110202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2022.110202</ArticleId><ArticleId IdType="pmc">PMC9727969</ArticleId><ArticleId IdType="pubmed">36496030</ArticleId></ArticleIdList></Reference><Reference><Citation>Nassar M., Daoud A., Nso N., Medina L., Ghernautan V., Bhangoo H., Nyein A., Mohamed M., Alqassieh A., Soliman K., et al. Diabetes Mellitus and COVID-19: Review Article. Diabetes Metab. Syndr. 2021;15:102268. doi: 10.1016/j.dsx.2021.102268.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.102268</ArticleId><ArticleId IdType="pmc">PMC8416292</ArticleId><ArticleId IdType="pubmed">34562865</ArticleId></ArticleIdList></Reference><Reference><Citation>Karampela I., Vallianou N., Magkos F., Apovian C.M., Dalamaga M. Obesity, Hypovitaminosis D, and COVID-19: The Bermuda Triangle in Public Health. Curr. Obes. Rep. 2022;11:116&#x2013;125. doi: 10.1007/s13679-022-00471-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13679-022-00471-3</ArticleId><ArticleId IdType="pmc">PMC8989103</ArticleId><ArticleId IdType="pubmed">35391661</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalamaga M., Christodoulatos G.S., Karampela I., Vallianou N., Apovian C.M. Understanding the Co-Epidemic of Obesity and COVID-19: Current Evidence, Comparison with Previous Epidemics, Mechanisms, and Preventive and Therapeutic Perspectives. Curr. Obes. Rep. 2021;10:214&#x2013;243. doi: 10.1007/s13679-021-00436-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13679-021-00436-y</ArticleId><ArticleId IdType="pmc">PMC8080486</ArticleId><ArticleId IdType="pubmed">33909265</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallianou N.G., Evangelopoulos A., Kounatidis D., Stratigou T., Christodoulatos G.S., Karampela I., Dalamaga M. Diabetes Mellitus and SARS-CoV-2 Infection: Pathophysiologic Mechanisms and Implications in Management. Curr. Diabetes Rev. 2021;17:e123120189797. doi: 10.2174/1573399817666210101110253.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1573399817666210101110253</ArticleId><ArticleId IdType="pubmed">33388022</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z. Diabetes after SARS-CoV-2 infection. Lancet. Diabetes Endocrinol. 2023;11:11&#x2013;13. doi: 10.1016/S2213-8587(22)00324-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(22)00324-2</ArticleId><ArticleId IdType="pmc">PMC9714974</ArticleId><ArticleId IdType="pubmed">36463908</ArticleId></ArticleIdList></Reference><Reference><Citation>Kendall E.K., Olaker V.R., Kaelber D.C., Xu R., Davis P.B. Association of SARS-CoV-2 Infection with New-Onset Type 1 Diabetes among Pediatric Patients from 2020 to 2021. JAMA Netw. Open. 2022;5:e2233014. doi: 10.1001/jamanetworkopen.2022.33014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.33014</ArticleId><ArticleId IdType="pmc">PMC9508649</ArticleId><ArticleId IdType="pubmed">36149658</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsilingiris D., Dalamaga M., Liu J. SARS-CoV-2 adipose tissue infection and hyperglycemia: A further step towards the understanding of severe COVID-19. Metab. Open. 2022;13:100163. doi: 10.1016/j.metop.2022.100163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metop.2022.100163</ArticleId><ArticleId IdType="pmc">PMC8755555</ArticleId><ArticleId IdType="pubmed">35039801</ArticleId></ArticleIdList></Reference><Reference><Citation>Tansey C.M., Louie M., Loeb M., Gold W.L., Muller M.P., de Jager J., Cameron J.I., Tomlinson G., Mazzulli T., Walmsley S.L., et al. One-year outcomes and health care utilization in survivors of severe acute respiratory syndrome. Arch. Intern. Med. 2007;167:1312&#x2013;1320. doi: 10.1001/archinte.167.12.1312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.167.12.1312</ArticleId><ArticleId IdType="pubmed">17592106</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam M.H., Wing Y.K., Yu M.W., Leung C.M., Ma R.C., Kong A.P., So W.Y., Fong S.Y., Lam S.P. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: Long-term follow-up. Arch. Intern. Med. 2009;169:2142&#x2013;2147. doi: 10.1001/archinternmed.2009.384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinternmed.2009.384</ArticleId><ArticleId IdType="pubmed">20008700</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S.H., Shin H.S., Park H.Y., Kim J.L., Lee J.J., Lee H., Won S.D., Han W. Depression as a Mediator of Chronic Fatigue and Post-Traumatic Stress Symptoms in Middle East Respiratory Syndrome Survivors. Psychiatry Investig. 2019;16:59&#x2013;64. doi: 10.30773/pi.2018.10.22.3.</Citation><ArticleIdList><ArticleId IdType="doi">10.30773/pi.2018.10.22.3</ArticleId><ArticleId IdType="pmc">PMC6354037</ArticleId><ArticleId IdType="pubmed">30605995</ArticleId></ArticleIdList></Reference><Reference><Citation>Moldofsky H., Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol. 2011;11:37. doi: 10.1186/1471-2377-11-37.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-11-37</ArticleId><ArticleId IdType="pmc">PMC3071317</ArticleId><ArticleId IdType="pubmed">21435231</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda K., Straus S.E., Hickie I., Sharpe M.C., Dobbins J.G., Komaroff A., International Chronic Fatigue Syndrome Study Group The chronic fatigue syndrome: A comprehensive approach to its definition and study. Ann. Intern. Med. 1994;121:953&#x2013;959. doi: 10.7326/0003-4819-121-12-199412150-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-121-12-199412150-00009</ArticleId><ArticleId IdType="pubmed">7978722</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC  Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Symptoms.  [(accessed on 17 May 2023)]; Available online:  https://www.cdc.gov/me-cfs/symptoms-diagnosis/symptoms.html.</Citation></Reference><Reference><Citation>Magnus P., Gunnes N., Tveito K., Bakken I.J., Ghaderi S., Stoltenberg C., Hornig M., Lipkin W.I., Trogstad L., H&#xe5;berg S.E. Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is associated with pandemic influenza infection, but not with an adjuvanted pandemic influenza vaccine. Vaccine. 2015;33:6173&#x2013;6177. doi: 10.1016/j.vaccine.2015.10.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2015.10.018</ArticleId><ArticleId IdType="pubmed">26475444</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson H.W., Amo-Addae M., Kenu E., Ilesanmi O.S., Ameme D.K., Sackey S.O. Post-Ebola Syndrome among Ebola Virus Disease Survivors in Montserrado County, Liberia 2016. BioMed Res. Int. 2018;2018:1909410. doi: 10.1155/2018/1909410.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/1909410</ArticleId><ArticleId IdType="pmc">PMC6046154</ArticleId><ArticleId IdType="pubmed">30050920</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia M.N., Hause A.M., Walker C.M., Orange J.S., Hasbun R., Murray K.O. Evaluation of prolonged fatigue post-West Nile virus infection and association of fatigue with elevated antiviral and proinflammatory cytokines. Viral Immunol. 2014;27:327&#x2013;333. doi: 10.1089/vim.2014.0035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/vim.2014.0035</ArticleId><ArticleId IdType="pmc">PMC4150370</ArticleId><ArticleId IdType="pubmed">25062274</ArticleId></ArticleIdList></Reference><Reference><Citation>Shikova E., Reshkova V., Kumanova A., Raleva S., Alexandrova D., Capo N., Murovska M. Cytomegalovirus, Epstein-Barr virus, and human herpesvirus-6 infections in patients with myalgic encephalomyelitis/chronic fatigue syndrome. J. Med. Virol. 2020;92:3682&#x2013;3688. doi: 10.1002/jmv.25744.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25744</ArticleId><ArticleId IdType="pmc">PMC7687071</ArticleId><ArticleId IdType="pubmed">32129496</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim E.J., Ahn Y.C., Jang E.S., Lee S.W., Lee S.H., Son C.G. Systematic review and meta-analysis of the prevalence of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) J. Transl. Med. 2020;18:100. doi: 10.1186/s12967-020-02269-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02269-0</ArticleId><ArticleId IdType="pmc">PMC7038594</ArticleId><ArticleId IdType="pubmed">32093722</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: A prospective observational study. Lancet. Respir. Med. 2022;10:761&#x2013;775. doi: 10.1016/S2213-2600(22)00127-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00127-8</ArticleId><ArticleId IdType="pmc">PMC9034855</ArticleId><ArticleId IdType="pubmed">35472304</ArticleId></ArticleIdList></Reference><Reference><Citation>Kritas S.K., Ronconi G., Caraffa A., Gallenga C.E., Ross R., Conti P. Mast cells contribute to coronavirus-induced inflammation: New anti-inflammatory strategy. J. Biol. Regul. Homeost. Agents. 2020;34:9&#x2013;14. doi: 10.23812/20-Editorial-Kritas.</Citation><ArticleIdList><ArticleId IdType="doi">10.23812/20-Editorial-Kritas</ArticleId><ArticleId IdType="pubmed">32013309</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner S., Khan M.A., Putrino D., Woodcock A., Kell D.B., Pretorius E. Long COVID: Pathophysiological factors and abnormalities of coagulation. Trends Endocrinol. Metab. 2023;34:321&#x2013;344. doi: 10.1016/j.tem.2023.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tem.2023.03.002</ArticleId><ArticleId IdType="pmc">PMC10113134</ArticleId><ArticleId IdType="pubmed">37080828</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu F., Chen F., Ou Z., Fan Q., Tan X., Wang Y., Pan Y., Ke B., Li L., Guan Y., et al. A compromised specific humoral immune response against the SARS-CoV-2 receptor-binding domain is related to viral persistence and periodic shedding in the gastrointestinal tract. Cell. Mol. Immunol. 2020;17:1119&#x2013;1125. doi: 10.1038/s41423-020-00550-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-00550-2</ArticleId><ArticleId IdType="pmc">PMC7546387</ArticleId><ArticleId IdType="pubmed">33037400</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C., Darley D.R., Wilson D.B., Howe A., Munier C.M.L., Patel S.K., Juno J.A., Burrell L.M., Kent S.J., Dore G.J., et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat. Immunol. 2022;23:210&#x2013;216. doi: 10.1038/s41590-021-01113-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinho J.R.R., Oliveira K.G., Sitnik R., Maluf M.M., Rodrigues P.H.S., Santana R.A.F., Welter E.R., Irony O. Long term persistence of coronavirus SARS-CoV-2 infection. Einstein. 2021;19:eRC6369. doi: 10.31744/einstein_journal/2021RC6369.</Citation><ArticleIdList><ArticleId IdType="doi">10.31744/einstein_journal/2021RC6369</ArticleId><ArticleId IdType="pmc">PMC8664288</ArticleId><ArticleId IdType="pubmed">34909977</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein S.R., Ramelli S.C., Grazioli A., Chung J.Y., Singh M., Yinda C.K., Winkler C.W., Sun J., Dickey J.M., Ylaya K., et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature. 2022;612:758&#x2013;763. doi: 10.1038/s41586-022-05542-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05542-y</ArticleId><ArticleId IdType="pmc">PMC9749650</ArticleId><ArticleId IdType="pubmed">36517603</ArticleId></ArticleIdList></Reference><Reference><Citation>Karn V., Ahmed S., Tsai L.W., Dubey R., Ojha S., Singh H.N., Kumar M., Gupta P.K., Sadhu S., Jha N.K., et al. Extracellular Vesicle-Based Therapy for COVID-19: Promises, Challenges and Future Prospects. Biomedicines. 2021;9:1373. doi: 10.3390/biomedicines9101373.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9101373</ArticleId><ArticleId IdType="pmc">PMC8533559</ArticleId><ArticleId IdType="pubmed">34680490</ArticleId></ArticleIdList></Reference><Reference><Citation>Vojdani A., Vojdani E., Saidara E., Maes M. Persistent SARS-CoV-2 Infection, EBV, HHV-6 and Other Factors May Contribute to Inflammation and Autoimmunity in Long COVID. Viruses. 2023;15:400. doi: 10.3390/v15020400.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15020400</ArticleId><ArticleId IdType="pmc">PMC9967513</ArticleId><ArticleId IdType="pubmed">36851614</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Abell&#xe1;n J., Padilla S., Fern&#xe1;ndez-Gonz&#xe1;lez M., Garc&#xed;a J.A., Agull&#xf3; V., Andreo M., Ruiz S., Galiana A., Guti&#xe9;rrez F., Masi&#xe1; M. Antibody Response to SARS-CoV-2 is Associated with Long-term Clinical Outcome in Patients with COVID-19: A Longitudinal Study. J. Clin. Immunol. 2021;41:1490&#x2013;1501. doi: 10.1007/s10875-021-01083-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-021-01083-7</ArticleId><ArticleId IdType="pmc">PMC8285689</ArticleId><ArticleId IdType="pubmed">34273064</ArticleId></ArticleIdList></Reference><Reference><Citation>Spatola M., Nziza N., Jung W., Deng Y., Yuan D., Dinoto A., Bozzetti S., Chiodega V., Ferrari S., Lauffenburger D.A., et al. Neurologic sequelae of COVID-19 are determined by immunologic imprinting from previous coronaviruses. Brain. 2023 doi: 10.1093/brain/awad155.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awad155</ArticleId><ArticleId IdType="pmc">PMC11004923</ArticleId><ArticleId IdType="pubmed">37161609</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal A.D., VanElzakker M.B. Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Front. Microbiol. 2021;12:698169. doi: 10.3389/fmicb.2021.698169.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Sausen D.G., Basith A., Muqeemuddin S. EBV and Lymphomagenesis. Cancers. 2023;15:2133. doi: 10.3390/cancers15072133.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers15072133</ArticleId><ArticleId IdType="pmc">PMC10093459</ArticleId><ArticleId IdType="pubmed">37046794</ArticleId></ArticleIdList></Reference><Reference><Citation>Lupo J., Truffot A., Andreani J., Habib M., Epaulard O., Morand P., Germi R. Virological Markers in Epstein-Barr Virus-Associated Diseases. Viruses. 2023;15:656. doi: 10.3390/v15030656.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15030656</ArticleId><ArticleId IdType="pmc">PMC10051789</ArticleId><ArticleId IdType="pubmed">36992365</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanz T.V., Brewer R.C., Ho P.P., Moon J.S., Jude K.M., Fernandez D., Fernandes R.A., Gomez A.M., Nadj G.S., Bartley C.M., et al. Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM. Nature. 2022;603:321&#x2013;327. doi: 10.1038/s41586-022-04432-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04432-7</ArticleId><ArticleId IdType="pmc">PMC9382663</ArticleId><ArticleId IdType="pubmed">35073561</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Toit A. EBV linked to multiple sclerosis. Nat. Rev. Microbiol. 2022;20:189. doi: 10.1038/s41579-022-00701-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00701-4</ArticleId><ArticleId IdType="pubmed">35110729</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallianou N.G., Tsilingiris D., Karampela I., Liu J., Dalamaga M. Herpes zoster following COVID-19 vaccination in an immunocompetent and vaccinated for herpes zoster adult: A two-vaccine related event? Metab. Open. 2022;13:100171. doi: 10.1016/j.metop.2022.100171.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metop.2022.100171</ArticleId><ArticleId IdType="pmc">PMC8830150</ArticleId><ArticleId IdType="pubmed">35169692</ArticleId></ArticleIdList></Reference><Reference><Citation>Argyrakopoulou G., Dalamaga M., Spyrou N., Kokkinos A. Gender Differences in Obesity-Related Cancers. Curr. Obes. Rep. 2021;10:100&#x2013;115. doi: 10.1007/s13679-021-00426-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13679-021-00426-0</ArticleId><ArticleId IdType="pubmed">33523397</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Leary K. Mounting evidence for EBV links to multiple sclerosis. Nat. Med. 2022;28:2450. doi: 10.1038/s41591-022-02151-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02151-0</ArticleId><ArticleId IdType="pubmed">36581755</ArticleId></ArticleIdList></Reference><Reference><Citation>Nekoua M.P., Alidjinou E.K., Hober D. Persistent coxsackievirus B infection and pathogenesis of type 1 diabetes mellitus. Nat. Rev. Endocrinol. 2022;18:503&#x2013;516. doi: 10.1038/s41574-022-00688-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-022-00688-1</ArticleId><ArticleId IdType="pmc">PMC9157043</ArticleId><ArticleId IdType="pubmed">35650334</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Cao Z.M., Zhang L.L., Dai X.C., Liu Z.J., Zeng Y.X., Li X.Y., Wu Q.J., Lv W.L. Helicobacter Pylori and Autoimmune Diseases: Involving Multiple Systems. Front. Immunol. 2022;13:833424. doi: 10.3389/fimmu.2022.833424.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.833424</ArticleId><ArticleId IdType="pmc">PMC8866759</ArticleId><ArticleId IdType="pubmed">35222423</ArticleId></ArticleIdList></Reference><Reference><Citation>Zangiabadian M., Mirsaeidi M., Pooyafar M.H., Goudarzi M., Nasiri M.J. Associations of Yersinia Enterocolitica Infection with Autoimmune Thyroid Diseases: A Systematic Review and Meta-Analysis. Endocr. Metab. Immune Disord. Drug Targets. 2021;21:682&#x2013;687. doi: 10.2174/1871530320666200621180515.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1871530320666200621180515</ArticleId><ArticleId IdType="pubmed">32564766</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwasaki A., Putrino D. Why we need a deeper understanding of the pathophysiology of long COVID. Lancet. Infect. Dis. 2023;23:393&#x2013;395. doi: 10.1016/S1473-3099(23)00053-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00053-1</ArticleId><ArticleId IdType="pmc">PMC9928485</ArticleId><ArticleId IdType="pubmed">36967698</ArticleId></ArticleIdList></Reference><Reference><Citation>Lake C.M., Breen J.J. Sequence similarity between SARS-CoV-2 nucleocapsid and multiple sclerosis-associated proteins provides insight into viral neuropathogenesis following infection. Sci. Rep. 2023;13:389. doi: 10.1038/s41598-022-27348-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-27348-8</ArticleId><ArticleId IdType="pmc">PMC9825799</ArticleId><ArticleId IdType="pubmed">36617594</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsilingiris D., Vallianou N.G., Karampela I., Dalamaga M. Vaccine induced thrombotic thrombocytopenia: The shady chapter of a success story. Metab. Open. 2021;11:100101. doi: 10.1016/j.metop.2021.100101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metop.2021.100101</ArticleId><ArticleId IdType="pmc">PMC8217988</ArticleId><ArticleId IdType="pubmed">34179744</ArticleId></ArticleIdList></Reference><Reference><Citation>Brogna C., Brogna B., Bisaccia D.R., Lauritano F., Marino G., Montano L., Cristoni S., Prisco M., Piscopo M. Could SARS-CoV-2 Have Bacteriophage Behavior or Induce the Activity of Other Bacteriophages? Vaccines. 2022;10:708. doi: 10.3390/vaccines10050708.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10050708</ArticleId><ArticleId IdType="pmc">PMC9143435</ArticleId><ArticleId IdType="pubmed">35632464</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T., Zhang F., Lui G.C.Y., Yeoh Y.K., Li A.Y.L., Zhan H., Wan Y., Chung A.C.K., Cheung C.P., Chen N., et al. Alterations in Gut Microbiota of Patients with COVID-19 during Time of Hospitalization. Gastroenterology. 2020;159:944&#x2013;955.e948. doi: 10.1053/j.gastro.2020.05.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.05.048</ArticleId><ArticleId IdType="pmc">PMC7237927</ArticleId><ArticleId IdType="pubmed">32442562</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallianou N., Kounatidis D., Christodoulatos G.S., Panagopoulos F., Karampela I., Dalamaga M. Mycobiome and Cancer: What Is the Evidence? Cancers. 2021;13:3149. doi: 10.3390/cancers13133149.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers13133149</ArticleId><ArticleId IdType="pmc">PMC8269322</ArticleId><ArticleId IdType="pubmed">34202433</ArticleId></ArticleIdList></Reference><Reference><Citation>Spyrou N., Vallianou N., Kadillari J., Dalamaga M. The interplay of obesity, gut microbiome and diet in the immune check point inhibitors therapy era. Semin. Cancer Biol. 2021;73:356&#x2013;376. doi: 10.1016/j.semcancer.2021.05.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcancer.2021.05.008</ArticleId><ArticleId IdType="pubmed">33989733</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallianou N., Dalamaga M., Stratigou T., Karampela I., Tsigalou C. Do Antibiotics Cause Obesity Through Long-term Alterations in the Gut Microbiome? A Review of Current Evidence. Curr. Obes. Rep. 2021;10:244&#x2013;262. doi: 10.1007/s13679-021-00438-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13679-021-00438-w</ArticleId><ArticleId IdType="pmc">PMC8093917</ArticleId><ArticleId IdType="pubmed">33945146</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsigalou C., Vallianou N., Dalamaga M. Autoantibody Production in Obesity: Is There Evidence for a Link Between Obesity and Autoimmunity? Curr. Obes. Rep. 2020;9:245&#x2013;254. doi: 10.1007/s13679-020-00397-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13679-020-00397-8</ArticleId><ArticleId IdType="pubmed">32632847</ArticleId></ArticleIdList></Reference><Reference><Citation>Koliaki C., Liatis S., Dalamaga M., Kokkinos A. The Implication of Gut Hormones in the Regulation of Energy Homeostasis and Their Role in the Pathophysiology of Obesity. Curr. Obes. Rep. 2020;9:255&#x2013;271. doi: 10.1007/s13679-020-00396-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13679-020-00396-9</ArticleId><ArticleId IdType="pubmed">32647952</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahamed J., Laurence J. Long COVID endotheliopathy: Hypothesized mechanisms and potential therapeutic approaches. J. Clin. Investig. 2022;132:2133. doi: 10.1172/JCI161167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI161167</ArticleId><ArticleId IdType="pmc">PMC9337829</ArticleId><ArticleId IdType="pubmed">35912863</ArticleId></ArticleIdList></Reference><Reference><Citation>Paniz-Mondolfi A., Bryce C., Grimes Z., Gordon R.E., Reidy J., Lednicky J., Sordillo E.M., Fowkes M. Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) J. Med. Virol. 2020;92:699&#x2013;702. doi: 10.1002/jmv.25915.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25915</ArticleId><ArticleId IdType="pmc">PMC7264598</ArticleId><ArticleId IdType="pubmed">32314810</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox S.E., Li G., Akmatbekov A., Harbert J.L., Lameira F.S., Brown J.Q., Vander Heide R.S. Unexpected Features of Cardiac Pathology in COVID-19 Infection. Circulation. 2020;142:1123&#x2013;1125. doi: 10.1161/CIRCULATIONAHA.120.049465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.049465</ArticleId><ArticleId IdType="pubmed">32689809</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J., Wang B., Xiang H., Cheng Z., Xiong Y., et al. Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. Jama. 2020;323:1061&#x2013;1069. doi: 10.1001/jama.2020.1585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.1585</ArticleId><ArticleId IdType="pmc">PMC7042881</ArticleId><ArticleId IdType="pubmed">32031570</ArticleId></ArticleIdList></Reference><Reference><Citation>Kassi E., Dalamaga M., Hroussalas G., Kazanis K., Merantzi G., Zachari A., Giamarellos-Bourboulis E.J., Dionyssiou-Asteriou A. Adipocyte factors, high-sensitive C-reactive protein levels and lipoxidative stress products in overweight postmenopausal women with normal and impaired OGTT. Maturitas. 2010;67:72&#x2013;77. doi: 10.1016/j.maturitas.2010.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.maturitas.2010.05.004</ArticleId><ArticleId IdType="pubmed">20570453</ArticleId></ArticleIdList></Reference><Reference><Citation>Hroussalas G., Kassi E., Dalamaga M., Delimaris I., Zachari A., Dionyssiou-Asteriou A. Leptin, soluble leptin receptor, adiponectin and resistin in relation to OGTT in overweight/obese postmenopausal women. Maturitas. 2008;59:339&#x2013;349. doi: 10.1016/j.maturitas.2008.03.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.maturitas.2008.03.012</ArticleId><ArticleId IdType="pubmed">18468820</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsilingiris D., Tzeravini E., Koliaki C., Dalamaga M., Kokkinos A. The Role of Mitochondrial Adaptation and Metabolic Flexibility in the Pathophysiology of Obesity and Insulin Resistance: An Updated Overview. Curr. Obes. Rep. 2021;10:191&#x2013;213. doi: 10.1007/s13679-021-00434-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13679-021-00434-0</ArticleId><ArticleId IdType="pubmed">33840072</ArticleId></ArticleIdList></Reference><Reference><Citation>Kassi E., Dalamaga M., Faviou E., Hroussalas G., Kazanis K., Nounopoulos C., Dionyssiou-Asteriou A. Circulating oxidized LDL levels, current smoking and obesity in postmenopausal women. Atherosclerosis. 2009;205:279&#x2013;283. doi: 10.1016/j.atherosclerosis.2008.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.atherosclerosis.2008.11.006</ArticleId><ArticleId IdType="pubmed">19110250</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunes J.M., Kruger A., Proal A., Kell D.B., Pretorius E. The Occurrence of Hyperactivated Platelets and Fibrinaloid Microclots in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Pharmaceuticals. 2022;15:931. doi: 10.3390/ph15080931.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph15080931</ArticleId><ArticleId IdType="pmc">PMC9413879</ArticleId><ArticleId IdType="pubmed">36015078</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang M., Wu X., Jing H., Novakovic V.A., Shi J. The intersection of obesity and (long) COVID-19: Hypoxia, thrombotic inflammation, and vascular endothelial injury. Front. Cardiovasc. Med. 2023;10:1062491. doi: 10.3389/fcvm.2023.1062491.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2023.1062491</ArticleId><ArticleId IdType="pmc">PMC9941162</ArticleId><ArticleId IdType="pubmed">36824451</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell D.B., Laubscher G.J., Pretorius E. A central role for amyloid fibrin microclots in long COVID/PASC: Origins and therapeutic implications. Biochem. J. 2022;479:537&#x2013;559. doi: 10.1042/BCJ20220016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BCJ20220016</ArticleId><ArticleId IdType="pmc">PMC8883497</ArticleId><ArticleId IdType="pubmed">35195253</ArticleId></ArticleIdList></Reference><Reference><Citation>Bansal R., Gubbi S., Koch C.A. COVID-19 and chronic fatigue syndrome: An endocrine perspective. J. Clin. Transl. Endocrinol. 2022;27:100284. doi: 10.1016/j.jcte.2021.100284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcte.2021.100284</ArticleId><ArticleId IdType="pmc">PMC8641402</ArticleId><ArticleId IdType="pubmed">34877261</ArticleId></ArticleIdList></Reference><Reference><Citation>Wheatland R. Molecular mimicry of ACTH in SARS&#x2014;Implications for corticosteroid treatment and prophylaxis. Med. Hypotheses. 2004;63:855&#x2013;862. doi: 10.1016/j.mehy.2004.04.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2004.04.009</ArticleId><ArticleId IdType="pmc">PMC7126000</ArticleId><ArticleId IdType="pubmed">15488660</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Hakeim H.K., Al-Rubaye H.T., Jubran A.S., Almulla A.F., Moustafa S.R., Maes M. Increased insulin resistance due to Long COVID is associated with depressive symptoms and partly predicted by the inflammatory response during acute infection. Braz. J. Psychiatry. 2023 doi: 10.47626/1516-4446-2022-3002.</Citation><ArticleIdList><ArticleId IdType="doi">10.47626/1516-4446-2022-3002</ArticleId><ArticleId IdType="pmc">PMC10288478</ArticleId><ArticleId IdType="pubmed">36917827</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodd S., Sominsky L., Siskind D., Bortolasci C.C., Carvalho A.F., Maes M., Walker A.J., Walder K., Yung A.R., Williams L.J., et al. The role of metformin as a treatment for neuropsychiatric illness. Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol. 2022;64:32&#x2013;43. doi: 10.1016/j.euroneuro.2022.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.euroneuro.2022.09.002</ArticleId><ArticleId IdType="pubmed">36191545</ArticleId></ArticleIdList></Reference><Reference><Citation>Scherer P.E., Kirwan J.P., Rosen C.J. Post-acute sequelae of COVID-19: A metabolic perspective. eLife. 2022;11:e78200. doi: 10.7554/eLife.78200.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.78200</ArticleId><ArticleId IdType="pmc">PMC8942467</ArticleId><ArticleId IdType="pubmed">35318939</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan D.X., Reiter R.J. Mechanisms and clinical evidence to support melatonin&#x2019;s use in severe COVID-19 patients to lower mortality. Life Sci. 2022;294:120368. doi: 10.1016/j.lfs.2022.120368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2022.120368</ArticleId><ArticleId IdType="pmc">PMC8800937</ArticleId><ArticleId IdType="pubmed">35108568</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardinali D.P., Brown G.M., Pandi-Perumal S.R. Possible Application of Melatonin in Long COVID. Biomolecules. 2022;12:1646. doi: 10.3390/biom12111646.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom12111646</ArticleId><ArticleId IdType="pmc">PMC9687267</ArticleId><ArticleId IdType="pubmed">36358996</ArticleId></ArticleIdList></Reference><Reference><Citation>Etter M.M., Martins T.A., Kulsvehagen L., P&#xf6;ssnecker E., Duchemin W., Hogan S., Sanabria-Diaz G., M&#xfc;ller J., Chiappini A., Rychen J., et al. Severe Neuro-COVID is associated with peripheral immune signatures, autoimmunity and neurodegeneration: A prospective cross-sectional study. Nat. Commun. 2022;13:6777. doi: 10.1038/s41467-022-34068-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-34068-0</ArticleId><ArticleId IdType="pmc">PMC9645766</ArticleId><ArticleId IdType="pubmed">36351919</ArticleId></ArticleIdList></Reference><Reference><Citation>Spudich S., Nath A. Nervous system consequences of COVID-19. Science. 2022;375:267&#x2013;269. doi: 10.1126/science.abm2052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm2052</ArticleId><ArticleId IdType="pubmed">35050660</ArticleId></ArticleIdList></Reference><Reference><Citation>Leng A., Shah M., Ahmad S.A., Premraj L., Wildi K., Li Bassi G., Pardo C.A., Choi A., Cho S.M. Pathogenesis Underlying Neurological Manifestations of Long COVID Syndrome and Potential Therapeutics. Cells. 2023;12:816. doi: 10.3390/cells12050816.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells12050816</ArticleId><ArticleId IdType="pmc">PMC10001044</ArticleId><ArticleId IdType="pubmed">36899952</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj S.R., Bourne K.M., Stiles L.E., Miglis M.G., Cortez M.M., Miller A.J., Freeman R., Biaggioni I., Rowe P.C., Sheldon R.S., et al. Postural orthostatic tachycardia syndrome (POTS): Priorities for POTS care and research from a 2019 National Institutes of Health Expert Consensus Meeting&#x2014;Part 2. Auton. Neurosci. Basic Clin. 2021;235:102836. doi: 10.1016/j.autneu.2021.102836.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autneu.2021.102836</ArticleId><ArticleId IdType="pmc">PMC8455430</ArticleId><ArticleId IdType="pubmed">34246578</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallukat G., Hohberger B., Wenzel K., F&#xfc;rst J., Schulze-Rothe S., Wallukat A., H&#xf6;nicke A.S., M&#xfc;ller J. Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms. J. Transl. Autoimmun. 2021;4:100100. doi: 10.1016/j.jtauto.2021.100100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtauto.2021.100100</ArticleId><ArticleId IdType="pmc">PMC8049853</ArticleId><ArticleId IdType="pubmed">33880442</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinaei R., Nejadbiglari H., Sinaei R., Zeinaly M., Pezeshki S., Jafari M. Finding positive SARS-CoV-2 RT-PCR in cerebrospinal fluid of two pediatric patients with severe COVID-19: A brief case report. BMC Pediatr. 2023;23:49. doi: 10.1186/s12887-022-03806-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12887-022-03806-0</ArticleId><ArticleId IdType="pmc">PMC9885917</ArticleId><ArticleId IdType="pubmed">36717816</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarius S., Pache F., K&#xf6;rtvelyessy P., Jel&#x10d;i&#x107; I., Stettner M., Franciotta D., Keller E., Neumann B., Ringelstein M., Senel M., et al. Cerebrospinal fluid findings in COVID-19: A multicenter study of 150 lumbar punctures in 127 patients. J. Neuroinflamm. 2022;19:19. doi: 10.1186/s12974-021-02339-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-021-02339-0</ArticleId><ArticleId IdType="pmc">PMC8771621</ArticleId><ArticleId IdType="pubmed">35057809</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xed;az-Resendiz K.J.G., Benitez-Trinidad A.B., Covantes-Rosales C.E., Toledo-Ibarra G.A., Ortiz-Lazareno P.C., Gir&#xf3;n-P&#xe9;rez D.A., Bueno-Dur&#xe1;n A.Y., P&#xe9;rez-D&#xed;az D.A., Barcelos-Garc&#xed;a R.G., Gir&#xf3;n-P&#xe9;rez M.I. Loss of mitochondrial membrane potential (&#x394;&#x3a8;(m)) in leucocytes as post-COVID-19 sequelae. J. Leukoc. Biol. 2022;112:23&#x2013;29. doi: 10.1002/JLB.3MA0322-279RRR.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JLB.3MA0322-279RRR</ArticleId><ArticleId IdType="pmc">PMC9088601</ArticleId><ArticleId IdType="pubmed">35355308</ArticleId></ArticleIdList></Reference><Reference><Citation>Guntur V.P., Nemkov T., de Boer E., Mohning M.P., Baraghoshi D., Cendali F.I., San-Mill&#xe1;n I., Petrache I., D&#x2019;Alessandro A. Signatures of Mitochondrial Dysfunction and Impaired Fatty Acid Metabolism in Plasma of Patients with Post-Acute Sequelae of COVID-19 (PASC) Metabolites. 2022;12:1026. doi: 10.3390/metabo12111026.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo12111026</ArticleId><ArticleId IdType="pmc">PMC9699059</ArticleId><ArticleId IdType="pubmed">36355108</ArticleId></ArticleIdList></Reference><Reference><Citation>Twomey R., DeMars J., Franklin K., Culos-Reed S.N., Weatherald J., Wrightson J.G. Chronic Fatigue and Postexertional Malaise in People Living with Long COVID: An Observational Study. Phys. Ther. 2022;102:pzac005. doi: 10.1093/ptj/pzac005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ptj/pzac005</ArticleId><ArticleId IdType="pmc">PMC9383197</ArticleId><ArticleId IdType="pubmed">35079817</ArticleId></ArticleIdList></Reference><Reference><Citation>Heerdt P.M., Shelley B., Singh I. Impaired systemic oxygen extraction long after mild COVID-19: Potential perioperative implications. Br. J. Anaesth. 2022;128:e246&#x2013;e249. doi: 10.1016/j.bja.2021.12.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2021.12.036</ArticleId><ArticleId IdType="pmc">PMC8710396</ArticleId><ArticleId IdType="pubmed">35067364</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul B.D., Lemle M.D., Komaroff A.L., Snyder S.H. Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome. Proc. Natl. Acad. Sci. USA. 2021;118:e2024358118. doi: 10.1073/pnas.2024358118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2024358118</ArticleId><ArticleId IdType="pmc">PMC8403932</ArticleId><ArticleId IdType="pubmed">34400495</ArticleId></ArticleIdList></Reference><Reference><Citation>de Boer E., Petrache I., Goldstein N.M., Olin J.T., Keith R.C., Modena B., Mohning M.P., Yunt Z.X., San-Mill&#xe1;n I., Swigris J.J. Decreased Fatty Acid Oxidation and Altered Lactate Production during Exercise in Patients with Post-acute COVID-19 Syndrome. Am. J. Respir. Crit. Care Med. 2022;205:126&#x2013;129. doi: 10.1164/rccm.202108-1903LE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202108-1903LE</ArticleId><ArticleId IdType="pmc">PMC8865580</ArticleId><ArticleId IdType="pubmed">34665688</ArticleId></ArticleIdList></Reference><Reference><Citation>Terpos E., Ntanasis-Stathopoulos I., Elalamy I., Kastritis E., Sergentanis T.N., Politou M., Psaltopoulou T., Gerotziafas G., Dimopoulos M.A. Hematological findings and complications of COVID-19. Am. J. Hematol. 2020;95:834&#x2013;847. doi: 10.1002/ajh.25829.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.25829</ArticleId><ArticleId IdType="pmc">PMC7262337</ArticleId><ArticleId IdType="pubmed">32282949</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G., Wu D., Guo W., Cao Y., Huang D., Wang H., Wang T., Zhang X., Chen H., Yu H., et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J. Clin. Investig. 2020;130:2620&#x2013;2629. doi: 10.1172/JCI137244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI137244</ArticleId><ArticleId IdType="pmc">PMC7190990</ArticleId><ArticleId IdType="pubmed">32217835</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotecha T., Knight D.S., Razvi Y., Kumar K., Vimalesvaran K., Thornton G., Patel R., Chacko L., Brown J.T., Coyle C., et al. Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance. Eur. Heart J. 2021;42:1866&#x2013;1878. doi: 10.1093/eurheartj/ehab075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab075</ArticleId><ArticleId IdType="pmc">PMC7928984</ArticleId><ArticleId IdType="pubmed">33596594</ArticleId></ArticleIdList></Reference><Reference><Citation>Helms J., Tacquard C., Severac F., Leonard-Lorant I., Ohana M., Delabranche X., Merdji H., Clere-Jehl R., Schenck M., Fagot Gandet F., et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: A multicenter prospective cohort study. Intensive Care Med. 2020;46:1089&#x2013;1098. doi: 10.1007/s00134-020-06062-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-06062-x</ArticleId><ArticleId IdType="pmc">PMC7197634</ArticleId><ArticleId IdType="pubmed">32367170</ArticleId></ArticleIdList></Reference><Reference><Citation>Karampela I., Christodoulatos G.S., Vallianou N., Tsilingiris D., Chrysanthopoulou E., Skyllas G., Antonakos G., Marinou I., Vogiatzakis E., Armaganidis A., et al. Circulating Chemerin and Its Kinetics May Be a Useful Diagnostic and Prognostic Biomarker in Critically Ill Patients with Sepsis: A Prospective Study. Biomolecules. 2022;12:301. doi: 10.3390/biom12020301.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom12020301</ArticleId><ArticleId IdType="pmc">PMC8869693</ArticleId><ArticleId IdType="pubmed">35204801</ArticleId></ArticleIdList></Reference><Reference><Citation>Karampela I., Christodoulatos G.S., Dalamaga M. The Role of Adipose Tissue and Adipokines in Sepsis: Inflammatory and Metabolic Considerations, and the Obesity Paradox. Curr. Obes. Rep. 2019;8:434&#x2013;457. doi: 10.1007/s13679-019-00360-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13679-019-00360-2</ArticleId><ArticleId IdType="pubmed">31637623</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalamaga M., Karmaniolas K., Nikolaidou A., Papadavid E. Hypocalcemia, hypomagnesemia, and hypokalemia following hydrofluoric acid chemical injury. J. Burn Care Res. Off. Publ. Am. Burn Assoc. 2008;29:541&#x2013;543. doi: 10.1097/BCR.0b013e3181711152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BCR.0b013e3181711152</ArticleId><ArticleId IdType="pubmed">18388571</ArticleId></ArticleIdList></Reference><Reference><Citation>Karampela I., Kandri E., Antonakos G., Vogiatzakis E., Christodoulatos G.S., Nikolaidou A., Dimopoulos G., Armaganidis A., Dalamaga M. Kinetics of circulating fetuin-A may predict mortality independently from adiponectin, high molecular weight adiponectin and prognostic factors in critically ill patients with sepsis: A prospective study. J. Crit. Care. 2017;41:78&#x2013;85. doi: 10.1016/j.jcrc.2017.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2017.05.004</ArticleId><ArticleId IdType="pubmed">28500919</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw B.H., Stiles L.E., Bourne K., Green E.A., Shibao C.A., Okamoto L.E., Garland E.M., Gamboa A., Diedrich A., Raj V., et al. The face of postural tachycardia syndrome&#x2014;Insights from a large cross-sectional online community-based survey. J. Intern. Med. 2019;286:438&#x2013;448. doi: 10.1111/joim.12895.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.12895</ArticleId><ArticleId IdType="pmc">PMC6790699</ArticleId><ArticleId IdType="pubmed">30861229</ArticleId></ArticleIdList></Reference><Reference><Citation>Houben-Wilke S., Go&#xeb;rtz Y.M., Delbressine J.M., Vaes A.W., Meys R., Machado F.V., van Herck M., Burtin C., Posthuma R., Franssen F.M., et al. The Impact of Long COVID-19 on Mental Health: Observational 6-Month Follow-Up Study. JMIR Ment. Health. 2022;9:e33704. doi: 10.2196/33704.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/33704</ArticleId><ArticleId IdType="pmc">PMC8914795</ArticleId><ArticleId IdType="pubmed">35200155</ArticleId></ArticleIdList></Reference><Reference><Citation>Naidu S.B., Shah A.J., Saigal A., Smith C., Brill S.E., Goldring J., Hurst J.R., Jarvis H., Lipman M., Mandal S. The high mental health burden of &#x201c;Long COVID&#x201d; and its association with on-going physical and respiratory symptoms in all adults discharged from hospital. Eur. Respir. J. 2021;57:2004364. doi: 10.1183/13993003.04364-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.04364-2020</ArticleId><ArticleId IdType="pmc">PMC8015645</ArticleId><ArticleId IdType="pubmed">33795319</ArticleId></ArticleIdList></Reference><Reference><Citation>Roca-Fernandez A., Wamil M., Telford A., Carapella V., Borlotti A., Monteiro D., Thomaides-Brears H., Kelly M., Dennis A., Banerjee R., et al. Cardiac abnormalities in Long COVID 1-year post-SARS-CoV-2 infection. Open Heart. 2023;10:e002241. doi: 10.1136/openhrt-2022-002241.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/openhrt-2022-002241</ArticleId><ArticleId IdType="pmc">PMC9950586</ArticleId><ArticleId IdType="pubmed">36822818</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes S.E., Haroon S., Subramanian A., McMullan C., Aiyegbusi O.L., Turner G.M., Jackson L., Davies E.H., Frost C., McNamara G., et al. Development and validation of the symptom burden questionnaire for long COVID (SBQ-LC): Rasch analysis. BMJ. 2022;377:e070230. doi: 10.1136/bmj-2022-070230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-070230</ArticleId><ArticleId IdType="pmc">PMC9043395</ArticleId><ArticleId IdType="pubmed">35477524</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamal S.M., Landers D.B., Hollenberg S.M., Turi Z.G., Glotzer T.V., Tancredi J., Parrillo J.E. Prospective Evaluation of Autonomic Dysfunction in Post-Acute Sequela of COVID-19. J. Am. Coll. Cardiol. 2022;79:2325&#x2013;2330. doi: 10.1016/j.jacc.2022.03.357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2022.03.357</ArticleId><ArticleId IdType="pmc">PMC8976261</ArticleId><ArticleId IdType="pubmed">35381331</ArticleId></ArticleIdList></Reference><Reference><Citation>Stavileci B., &#xd6;zdemir E., &#xd6;zdemir B., Ereren E., Cengiz M. De-novo development of fragmented QRS during a six-month follow-up period in patients with COVID-19 disease and its cardiac effects. J. Electrocardiol. 2022;72:44&#x2013;48. doi: 10.1016/j.jelectrocard.2022.02.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jelectrocard.2022.02.012</ArticleId><ArticleId IdType="pmc">PMC8917010</ArticleId><ArticleId IdType="pubmed">35306293</ArticleId></ArticleIdList></Reference><Reference><Citation>Grist J.T., Collier G.J., Walters H., Kim M., Chen M., Abu Eid G., Laws A., Matthews V., Jacob K., Cross S., et al. Lung Abnormalities Detected with Hyperpolarized (129)Xe MRI in Patients with Long COVID. Radiology. 2022;305:709&#x2013;717. doi: 10.1148/radiol.220069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.220069</ArticleId><ArticleId IdType="pmc">PMC9134268</ArticleId><ArticleId IdType="pubmed">35608443</ArticleId></ArticleIdList></Reference><Reference><Citation>Bateman L., Bested A.C., Bonilla H.F., Chheda B.V., Chu L., Curtin J.M., Dempsey T.T., Dimmock M.E., Dowell T.G., Felsenstein D., et al. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Essentials of Diagnosis and Management. Mayo Clin. Proc. 2021;96:2861&#x2013;2878. doi: 10.1016/j.mayocp.2021.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2021.07.004</ArticleId><ArticleId IdType="pubmed">34454716</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J., Halim A., Halim M., Liu S., Aljeldah M., Al Shammari B.R., Alwarthan S., Alhajri M., Alawfi A., Alshengeti A., et al. Inflammatory and vascular biomarkers in post-COVID-19 syndrome: A systematic review and meta-analysis of over 20 biomarkers. Rev. Med. Virol. 2023;33:e2424. doi: 10.1002/rmv.2424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2424</ArticleId><ArticleId IdType="pubmed">36708022</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin J.X., Agbana Y.L., Sun Z.S., Fei S.W., Zhao H.Q., Zhou X.N., Chen J.H., Kassegne K. Increased interleukin-6 is associated with long COVID-19: A systematic review and meta-analysis. Infect. Dis. Poverty. 2023;12:43. doi: 10.1186/s40249-023-01086-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40249-023-01086-z</ArticleId><ArticleId IdType="pmc">PMC10123579</ArticleId><ArticleId IdType="pubmed">37095536</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein J., Wood J., Jaycox J., Lu P., Dhodapkar R.M., Gehlhausen J.R., Tabachnikova A., Tabacof L., Malik A.A., Kamath K., et al. Distinguishing features of Long COVID identified through immune profiling. medRxiv. 2022 doi: 10.1101/2022.08.09.22278592.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.08.09.22278592</ArticleId><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>Haunhorst S., Bloch W., Javelle F., Kr&#xfc;ger K., Baumgart S., Drube S., Lemh&#xf6;fer C., Reuken P., Stallmach A., M&#xfc;ller M., et al. A scoping review of regulatory T cell dynamics in convalescent COVID-19 patients&#x2014;Indications for their potential involvement in the development of Long COVID? Front. Immunol. 2022;13:1070994. doi: 10.3389/fimmu.2022.1070994.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1070994</ArticleId><ArticleId IdType="pmc">PMC9792979</ArticleId><ArticleId IdType="pubmed">36582234</ArticleId></ArticleIdList></Reference><Reference><Citation>Gal&#xe1;n M., Vig&#xf3;n L., Fuertes D., Murciano-Ant&#xf3;n M.A., Casado-Fern&#xe1;ndez G., Dom&#xed;nguez-Mateos S., Mateos E., Ramos-Mart&#xed;n F., Planelles V., Torres M., et al. Persistent Overactive Cytotoxic Immune Response in a Spanish Cohort of Individuals with Long-COVID: Identification of Diagnostic Biomarkers. Front. Immunol. 2022;13:848886. doi: 10.3389/fimmu.2022.848886.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.848886</ArticleId><ArticleId IdType="pmc">PMC8990790</ArticleId><ArticleId IdType="pubmed">35401523</ArticleId></ArticleIdList></Reference><Reference><Citation>Utrero-Rico A., Ruiz-Ruig&#xf3;mez M., Laguna-Goya R., Arrieta-Ortubay E., Chivite-Lacaba M., Gonz&#xe1;lez-Cuadrado C., Lalueza A., Almendro-Vazquez P., Serrano A., Aguado J.M., et al. A Short Corticosteroid Course Reduces Symptoms and Immunological Alterations Underlying Long-COVID. Biomedicines. 2021;9:1540. doi: 10.3390/biomedicines9111540.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9111540</ArticleId><ArticleId IdType="pmc">PMC8614904</ArticleId><ArticleId IdType="pubmed">34829769</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson B.K., Guevara-Coto J., Yogendra R., Francisco E.B., Long E., Pise A., Rodrigues H., Parikh P., Mora J., Mora-Rodr&#xed;guez R.A. Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine Learning. Front. Immunol. 2021;12:700782. doi: 10.3389/fimmu.2021.700782.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.700782</ArticleId><ArticleId IdType="pmc">PMC8273732</ArticleId><ArticleId IdType="pubmed">34262570</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank Z., Senussi Y., Manickas-Hill Z., Yu X.G., Li J.Z., Alter G., Walt D.R. Persistent Circulating Severe Acute Respiratory Syndrome Coronavirus 2 Spike Is Associated with Post-acute Coronavirus Disease 2019 Sequelae. Clin. Infect. Dis. 2023;76:e487&#x2013;e490. doi: 10.1093/cid/ciac722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac722</ArticleId><ArticleId IdType="pmc">PMC10169416</ArticleId><ArticleId IdType="pubmed">36052466</ArticleId></ArticleIdList></Reference><Reference><Citation>Natarajan A., Zlitni S., Brooks E.F., Vance S.E., Dahlen A., Hedlin H., Park R.M., Han A., Schmidtke D.T., Verma R., et al. Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection. Med. 2022;3:371&#x2013;387.e379. doi: 10.1016/j.medj.2022.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medj.2022.04.001</ArticleId><ArticleId IdType="pmc">PMC9005383</ArticleId><ArticleId IdType="pubmed">35434682</ArticleId></ArticleIdList></Reference><Reference><Citation>Tejerina F., Catalan P., Rodriguez-Grande C., Adan J., Rodriguez-Gonzalez C., Mu&#xf1;oz P., Aldamiz T., Diez C., Perez L., Fanciulli C., et al. Post-COVID-19 syndrome. SARS-CoV-2 RNA detection in plasma, stool, and urine in patients with persistent symptoms after COVID-19. BMC Infect. Dis. 2022;22:211. doi: 10.1186/s12879-022-07153-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07153-4</ArticleId><ArticleId IdType="pmc">PMC8892394</ArticleId><ArticleId IdType="pubmed">35240997</ArticleId></ArticleIdList></Reference><Reference><Citation>Zollner A., Koch R., Jukic A., Pfister A., Meyer M., R&#xf6;ssler A., Kimpel J., Adolph T.E., Tilg H. Postacute COVID-19 is Characterized by Gut Viral Antigen Persistence in Inflammatory Bowel Diseases. Gastroenterology. 2022;163:495&#x2013;506.e498. doi: 10.1053/j.gastro.2022.04.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2022.04.037</ArticleId><ArticleId IdType="pmc">PMC9057012</ArticleId><ArticleId IdType="pubmed">35508284</ArticleId></ArticleIdList></Reference><Reference><Citation>Yonker L.M., Gilboa T., Ogata A.F., Senussi Y., Lazarovits R., Boribong B.P., Bartsch Y.C., Loiselle M., Rivas M.N., Porritt R.A., et al. Multisystem inflammatory syndrome in children is driven by zonulin-dependent loss of gut mucosal barrier. J. Clin. Investig. 2021;131 doi: 10.1172/JCI149633.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI149633</ArticleId><ArticleId IdType="pmc">PMC8279585</ArticleId><ArticleId IdType="pubmed">34032635</ArticleId></ArticleIdList></Reference><Reference><Citation>Files J.K., Sarkar S., Fram T.R., Boppana S., Sterrett S., Qin K., Bansal A., Long D.M., Sabbaj S., Kobie J.J., et al. Duration of post-COVID-19 symptoms is associated with sustained SARS-CoV-2-specific immune responses. JCI Insight. 2021;6:e151544. doi: 10.1172/jci.insight.151544.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.151544</ArticleId><ArticleId IdType="pmc">PMC8410022</ArticleId><ArticleId IdType="pubmed">34143754</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin M., Schommers P., Stecher M., Dewald F., Gieselmann L., Gruell H., Horn C., Vanshylla K., Cristanziano V.D., Osebold L., et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: A longitudinal prospective cohort study. Lancet Reg. Health. Eur. 2021;6:100122. doi: 10.1016/j.lanepe.2021.100122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100122</ArticleId><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B., Mohn K.G., Brokstad K.A., Zhou F., Linchausen D.W., Hansen B.A., Lartey S., Onyango T.B., Kuwelker K., S&#xe6;vik M., et al. Long COVID in a prospective cohort of home-isolated patients. Nat. Med. 2021;27:1607&#x2013;1613. doi: 10.1038/s41591-021-01433-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01433-3</ArticleId><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Deitchman A.N., Torres L., Iyer N.S., Munter S.E., Nixon C.C., Donatelli J., Thanh C., Takahashi S., Hakim J., et al. Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms. Cell Rep. 2021;36:109518. doi: 10.1016/j.celrep.2021.109518.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109518</ArticleId><ArticleId IdType="pmc">PMC8342976</ArticleId><ArticleId IdType="pubmed">34358460</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Deveau T.M., Munter S.E., Ryder D., Buck A., Beck-Engeser G., Chan F., Lu S., Goldberg S.A., Hoh R., et al. Chronic viral coinfections differentially affect the likelihood of developing long COVID. J. Clin. Investig. 2023;133 doi: 10.1172/JCI163669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI163669</ArticleId><ArticleId IdType="pmc">PMC9888380</ArticleId><ArticleId IdType="pubmed">36454631</ArticleId></ArticleIdList></Reference><Reference><Citation>Zubchenko S., Kril I., Nadizhko O., Matsyura O., Chopyak V. Herpesvirus infections and post-COVID-19 manifestations: A pilot observational study. Rheumatol. Int. 2022;42:1523&#x2013;1530. doi: 10.1007/s00296-022-05146-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-022-05146-9</ArticleId><ArticleId IdType="pmc">PMC9159383</ArticleId><ArticleId IdType="pubmed">35650445</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Yuan D., Chen D.G., Ng R.H., Wang K., Choi J., Li S., Hong S., Zhang R., Xie J., et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185:881&#x2013;895.e820. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold J.E., Okyay R.A., Licht W.E., Hurley D.J. Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation. Pathogens. 2021;10:763. doi: 10.3390/pathogens10060763.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens10060763</ArticleId><ArticleId IdType="pmc">PMC8233978</ArticleId><ArticleId IdType="pubmed">34204243</ArticleId></ArticleIdList></Reference><Reference><Citation>Muri J., Cecchinato V., Cavalli A., Shanbhag A.A., Matkovic M., Biggiogero M., Maida P.A., Moritz J., Toscano C., Ghovehoud E., et al. Autoantibodies against chemokines post-SARS-CoV-2 infection correlate with disease course. Nat. Immunol. 2023;24:604&#x2013;611. doi: 10.1038/s41590-023-01445-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-023-01445-w</ArticleId><ArticleId IdType="pmc">PMC10063443</ArticleId><ArticleId IdType="pubmed">36879067</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodansky A., Wang C.Y., Saxena A., Mitchell A., Takahashi S., Anglin K., Huang B., Hoh R., Lu S., Goldberg S.A., et al. Autoantigen profiling reveals a shared post-COVID signature in fully recovered and Long COVID patients. medRxiv. 2023 doi: 10.1172/jci.insight.169515.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.169515</ArticleId><ArticleId IdType="pmc">PMC10393220</ArticleId><ArticleId IdType="pubmed">37288661</ArticleId></ArticleIdList></Reference><Reference><Citation>Son K., Jamil R., Chowdhury A., Mukherjee M., Venegas C., Miyasaki K., Zhang K., Patel Z., Salter B., Yuen A.C.Y., et al. Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long COVID symptoms. Eur. Respir. J. 2023;61:2200970. doi: 10.1183/13993003.00970-2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00970-2022</ArticleId><ArticleId IdType="pmc">PMC9515477</ArticleId><ArticleId IdType="pubmed">36137590</ArticleId></ArticleIdList></Reference><Reference><Citation>Franke C., Boesl F., Goereci Y., Gerhard A., Schweitzer F., Schroeder M., Foverskov-Rasmussen H., Heine J., Quitschau A., Kandil F.I., et al. Association of cerebrospinal fluid brain-binding autoantibodies with cognitive impairment in post-COVID-19 syndrome. Brain Behav. Immun. 2023;109:139&#x2013;143. doi: 10.1016/j.bbi.2023.01.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2023.01.006</ArticleId><ArticleId IdType="pmc">PMC9841734</ArticleId><ArticleId IdType="pubmed">36657623</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Mitchell A., Wang C.Y., Takahashi S., Hoh R., Tai V., Durstenfeld M.S., Hsue P.Y., Kelly J.D., Martin J.N., et al. Low Prevalence of Interferon &#x3b1; Autoantibodies in People Experiencing Symptoms of Post-Coronavirus Disease 2019 (COVID-19) Conditions, or Long COVID. J. Infect. Dis. 2023;227:246&#x2013;250. doi: 10.1093/infdis/jiac372.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac372</ArticleId><ArticleId IdType="pmc">PMC9494362</ArticleId><ArticleId IdType="pubmed">36089700</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas M., Rodr&#xed;guez Y., Acosta-Ampudia Y., Monsalve D.M., Zhu C., Li Q.Z., Ram&#xed;rez-Santana C., Anaya J.M. Autoimmunity is a hallmark of post-COVID syndrome. J. Transl. Med. 2022;20:129. doi: 10.1186/s12967-022-03328-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03328-4</ArticleId><ArticleId IdType="pmc">PMC8924736</ArticleId><ArticleId IdType="pubmed">35296346</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel M.A., Knauer M.J., Nicholson M., Daley M., Van Nynatten L.R., Martin C., Patterson E.K., Cepinskas G., Seney S.L., Dobretzberger V., et al. Elevated vascular transformation blood biomarkers in Long-COVID indicate angiogenesis as a key pathophysiological mechanism. Mol. Med. 2022;28:122. doi: 10.1186/s10020-022-00548-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10020-022-00548-8</ArticleId><ArticleId IdType="pmc">PMC9549814</ArticleId><ArticleId IdType="pubmed">36217108</ArticleId></ArticleIdList></Reference><Reference><Citation>Haffke M., Freitag H., Rudolf G., Seifert M., Doehner W., Scherbakov N., Hanitsch L., Wittke K., Bauer S., Konietschke F., et al. Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS) J. Transl. Med. 2022;20:138. doi: 10.1186/s12967-022-03346-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03346-2</ArticleId><ArticleId IdType="pmc">PMC8938726</ArticleId><ArticleId IdType="pubmed">35317812</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong M., Yan X., Jiang Y., Jin Z., Zhu S., Zou L., Liu Y., Zheng Q., Chen G., Gu R., et al. Endothelial Biomarkers in Patients Recovered from COVID-19 One Year after Hospital Discharge: A Cross-Sectional Study. Mediterr. J. Hematol. Infect. Dis. 2022;14:e2022033. doi: 10.4084/MJHID.2022.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.4084/MJHID.2022.033</ArticleId><ArticleId IdType="pmc">PMC9084173</ArticleId><ArticleId IdType="pubmed">35615329</ArticleId></ArticleIdList></Reference><Reference><Citation>Constantinescu-Bercu A., Kessler A., de Groot R., Dragunaite B., Heightman M., Hillman T., Price L.C., Brennan E., Sivera R., Vanhoorelbeke K., et al. Analysis of thrombogenicity under flow reveals new insights into the prothrombotic state of patients with post-COVID syndrome. J. Thromb. Haemost. JTH. 2023;21:94&#x2013;100. doi: 10.1016/j.jtha.2022.10.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtha.2022.10.013</ArticleId><ArticleId IdType="pmc">PMC9773628</ArticleId><ArticleId IdType="pubmed">36695401</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Gennaro L., Valentini P., Sorrentino S., Ferretti M.A., De Candia E., Basso M., Lancellotti S., De Cristofaro R., De Rose C., Mariani F., et al. Extended coagulation profile of children with Long COVID: A prospective study. Sci. Rep. 2022;12:18392. doi: 10.1038/s41598-022-23168-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-23168-y</ArticleId><ArticleId IdType="pmc">PMC9626616</ArticleId><ArticleId IdType="pubmed">36319840</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruger A., Vlok M., Turner S., Venter C., Laubscher G.J., Kell D.B., Pretorius E. Proteomics of fibrin amyloid microclots in long COVID/post-acute sequelae of COVID-19 (PASC) shows many entrapped pro-inflammatory molecules that may also contribute to a failed fibrinolytic system. Cardiovasc. Diabetol. 2022;21:190. doi: 10.1186/s12933-022-01623-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-022-01623-4</ArticleId><ArticleId IdType="pmc">PMC9491257</ArticleId><ArticleId IdType="pubmed">36131342</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Vlok M., Venter C., Bezuidenhout J.A., Laubscher G.J., Steenkamp J., Kell D.B. Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc. Diabetol. 2021;20:172. doi: 10.1186/s12933-021-01359-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-021-01359-7</ArticleId><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>di Filippo L., Frara S., Nannipieri F., Cotellessa A., Locatelli M., Rovere Querini P., Giustina A. Low vitamin D levels are associated with Long COVID syndrome in COVID-19 survivors. J. Clin. Endocrinol. Metab. 2023 doi: 10.1210/clinem/dgad207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgad207</ArticleId><ArticleId IdType="pmc">PMC10505553</ArticleId><ArticleId IdType="pubmed">37051747</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamed Hussein A.A.R., Galal I., Amin M.T., Moshnib A.A., Makhlouf N.A., Makhlouf H.A., Abd-Elaal H.K., Kholief K.M.S., Abdel Tawab D.A., Kamal Eldin K.A., et al. Prevalence of vitamin D deficiency among patients attending Post COVID-19 follow-up clinic: A cross-sectional study. Eur. Rev. Med. Pharmacol. Sci. 2022;26:3038&#x2013;3045. doi: 10.26355/eurrev_202204_28635.</Citation><ArticleIdList><ArticleId IdType="doi">10.26355/eurrev_202204_28635</ArticleId><ArticleId IdType="pubmed">35503606</ArticleId></ArticleIdList></Reference><Reference><Citation>Sunada N., Honda H., Nakano Y., Yamamoto K., Tokumasu K., Sakurada Y., Matsuda Y., Hasegawa T., Otsuka Y., Obika M., et al. Hormonal trends in patients suffering from long COVID symptoms. Endocr. J. 2022;69:1173&#x2013;1181. doi: 10.1507/endocrj.EJ22-0093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1507/endocrj.EJ22-0093</ArticleId><ArticleId IdType="pubmed">35491089</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., Dyer A.H., McCluskey P., O&#x2019;Brien K., Dowds J., Laird E., Bannan C., Bourke N.M., Cheallaigh C.N., Byrne D.G., et al. Investigating the Relationship between Vitamin D and Persistent Symptoms Following SARS-CoV-2 Infection. Nutrients. 2021;13:2430. doi: 10.3390/nu13072430.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13072430</ArticleId><ArticleId IdType="pmc">PMC8308626</ArticleId><ArticleId IdType="pubmed">34371940</ArticleId></ArticleIdList></Reference><Reference><Citation>Captur G., Moon J.C., Topriceanu C.C., Joy G., Swadling L., Hallqvist J., Doykov I., Patel N., Spiewak J., Baldwin T., et al. Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infection. EBioMedicine. 2022;85:104293. doi: 10.1016/j.ebiom.2022.104293.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.104293</ArticleId><ArticleId IdType="pmc">PMC9515404</ArticleId><ArticleId IdType="pubmed">36182629</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Hern&#xe1;ndez Y., Oropeza-Valdez J.J., Garc&#xed;a Lopez D.A., Borrego J.C., Murgu M., Valdez J., L&#xf3;pez J.A., Mon&#xe1;rrez-Espino J. Untargeted analysis in post-COVID-19 patients reveals dysregulated lipid pathways two years after recovery. Front. Mol. Biosci. 2023;10:1100486. doi: 10.3389/fmolb.2023.1100486.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2023.1100486</ArticleId><ArticleId IdType="pmc">PMC10022496</ArticleId><ArticleId IdType="pubmed">36936993</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Hern&#xe1;ndez Y., Aquino J.M., L&#xf3;pez D.A.G., Zheng J., Borrego J.C., Torres-Calzada C., Elizalde-D&#xed;az J.P., Mandal R., Berjanskii M., Mart&#xed;nez-Mart&#xed;nez E., et al. The plasma metabolome of long COVID-19 patients two years after infection. medRxiv. 2023 doi: 10.1101/2023.05.03.23289456.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.05.03.23289456</ArticleId><ArticleId IdType="pmc">PMC10394026</ArticleId><ArticleId IdType="pubmed">37528111</ArticleId></ArticleIdList></Reference><Reference><Citation>Cysique L.A., Jakabek D., Bracken S.G., Allen-Davidian Y., Heng B., Chow S., Dehhaghi M., Pires A.S., Darley D.R., Byrne A., et al. Post-acute COVID-19 cognitive impairment and decline uniquely associate with kynurenine pathway activation: A longitudinal observational study. medRxiv. 2022 doi: 10.1101/2022.06.07.22276020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.06.07.22276020</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang D., Zhou Y., Ma Y., Chen P., Tang J., Yang B., Li H., Liang M., Xue Y., Liu Y., et al. Gut Microbiota Dysbiosis Correlates with Long COVID-19 at One-Year After Discharge. J. Korean Med. Sci. 2023;38:e120. doi: 10.3346/jkms.2023.38.e120.</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2023.38.e120</ArticleId><ArticleId IdType="pmc">PMC10111044</ArticleId><ArticleId IdType="pubmed">37069814</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q., Mak J.W.Y., Su Q., Yeoh Y.K., Lui G.C., Ng S.S.S., Zhang F., Li A.Y.L., Lu W., Hui D.S., et al. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut. 2022;71:544&#x2013;552. doi: 10.1136/gutjnl-2021-325989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-325989</ArticleId><ArticleId IdType="pubmed">35082169</ArticleId></ArticleIdList></Reference><Reference><Citation>Apple A.C., Oddi A., Peluso M.J., Asken B.M., Henrich T.J., Kelly J.D., Pleasure S.J., Deeks S.G., Allen I.E., Martin J.N., et al. Risk factors and abnormal cerebrospinal fluid associate with cognitive symptoms after mild COVID-19. Ann. Clin. Transl. Neurol. 2022;9:221&#x2013;226. doi: 10.1002/acn3.51498.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51498</ArticleId><ArticleId IdType="pmc">PMC8862406</ArticleId><ArticleId IdType="pubmed">35043593</ArticleId></ArticleIdList></Reference><Reference><Citation>Guasp M., Mu&#xf1;oz-S&#xe1;nchez G., Mart&#xed;nez-Hern&#xe1;ndez E., Santana D., Carbayo &#xc1;., Naranjo L., Bol&#xf3;s U., Framil M., Saiz A., Balasa M., et al. CSF Biomarkers in COVID-19 Associated Encephalopathy and Encephalitis Predict Long-Term Outcome. Front. Immunol. 2022;13:866153. doi: 10.3389/fimmu.2022.866153.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.866153</ArticleId><ArticleId IdType="pmc">PMC9035899</ArticleId><ArticleId IdType="pubmed">35479062</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonnet B., Cosme J., Dupuis C., Coupez E., Adda M., Calvet L., Fabre L., Saint-Sardos P., Bereiziat M., Vidal M., et al. Severe COVID-19 is characterized by the co-occurrence of moderate cytokine inflammation and severe monocyte dysregulation. EBioMedicine. 2021;73:103622. doi: 10.1016/j.ebiom.2021.103622.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103622</ArticleId><ArticleId IdType="pmc">PMC8526358</ArticleId><ArticleId IdType="pubmed">34678611</ArticleId></ArticleIdList></Reference><Reference><Citation>Montazersaheb S., Hosseiniyan Khatibi S.M., Hejazi M.S., Tarhriz V., Farjami A., Ghasemian Sorbeni F., Farahzadi R., Ghasemnejad T. COVID-19 infection: An overview on cytokine storm and related interventions. Virol. J. 2022;19:92. doi: 10.1186/s12985-022-01814-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-022-01814-1</ArticleId><ArticleId IdType="pmc">PMC9134144</ArticleId><ArticleId IdType="pubmed">35619180</ArticleId></ArticleIdList></Reference><Reference><Citation>Low R.N., Low R.J., Akrami A. A review of cytokine-based pathophysiology of Long COVID symptoms. Front. Med. 2023;10:1011936. doi: 10.3389/fmed.2023.1011936.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1011936</ArticleId><ArticleId IdType="pmc">PMC10103649</ArticleId><ArticleId IdType="pubmed">37064029</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Lu S., Tang A.F., Durstenfeld M.S., Ho H.E., Goldberg S.A., Forman C.A., Munter S.E., Hoh R., Tai V., et al. Markers of Immune Activation and Inflammation in Individuals with Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection. J. Infect. Dis. 2021;224:1839&#x2013;1848. doi: 10.1093/infdis/jiab490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab490</ArticleId><ArticleId IdType="pmc">PMC8643408</ArticleId><ArticleId IdType="pubmed">34677601</ArticleId></ArticleIdList></Reference><Reference><Citation>Littlefield K.M., Watson R.O., Schneider J.M., Neff C.P., Yamada E., Zhang M., Campbell T.B., Falta M.T., Jolley S.E., Fontenot A.P., et al. SARS-CoV-2-specific T cells associate with inflammation and reduced lung function in pulmonary post-acute sequalae of SARS-CoV-2. PLoS Pathog. 2022;18:e1010359. doi: 10.1371/journal.ppat.1010359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1010359</ArticleId><ArticleId IdType="pmc">PMC9176759</ArticleId><ArticleId IdType="pubmed">35617421</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortellini A., Gennari A., Pommeret F., Patel G., Newsom-Davis T., Bertuzzi A., Viladot M., Aguilar-Company J., Mirallas O., Felip E., et al. COVID-19 Sequelae and the Host Proinflammatory Response: An Analysis from the OnCovid Registry. J. Natl. Cancer Inst. 2022;114:979&#x2013;987. doi: 10.1093/jnci/djac057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnci/djac057</ArticleId><ArticleId IdType="pmc">PMC9047221</ArticleId><ArticleId IdType="pubmed">35417006</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu S.J., Weng Z.C. [Influence of stimulation of the skin receptive field on evoked discharges of the polymodal nociceptors in rats] Sheng Li Xue Bao. 1988;40:437&#x2013;443.</Citation><ArticleIdList><ArticleId IdType="pubmed">3251356</ArticleId></ArticleIdList></Reference><Reference><Citation>Queiroz M.A.F., Neves P., Lima S.S., Lopes J.D.C., Torres M., Vallinoto I., Bichara C.D.A., Dos Santos E.F., de Brito M., da Silva A.L.S., et al. Cytokine Profiles Associated with Acute COVID-19 and Long COVID-19 Syndrome. Front. Cell. Infect. Microbiol. 2022;12:922422. doi: 10.3389/fcimb.2022.922422.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.922422</ArticleId><ArticleId IdType="pmc">PMC9279918</ArticleId><ArticleId IdType="pubmed">35846757</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Casta&#xf1;eda A., Lu P., Geraghty A.C., Song E., Lee M.H., Wood J., Yal&#xe7;&#x131;n B., Taylor K.R., Dutton S., Acosta-Alvarez L., et al. Mild respiratory SARS-CoV-2 infection can cause multi-lineage cellular dysregulation and myelin loss in the brain. bioRxiv. 2022 doi: 10.1101/2022.01.07.475453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.01.07.475453</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkataramani V., Winkler F. Cognitive Deficits in Long COVID-19. New Engl. J. Med. 2022;387:1813&#x2013;1815. doi: 10.1056/NEJMcibr2210069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMcibr2210069</ArticleId><ArticleId IdType="pubmed">36351274</ArticleId></ArticleIdList></Reference><Reference><Citation>da Silva R., de Sarges K.M.L., Cantanhede M.H.D., da Costa F.P., Dos Santos E.F., Rodrigues F.B.B., de Nazar&#xe9; do Socorro de Almeida Viana M., de Meira Leite M., da Silva A.L.S., de Brito M.T.M., et al. Thrombophilia and Immune-Related Genetic Markers in Long COVID. Viruses. 2023;15:885. doi: 10.3390/v15040885.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15040885</ArticleId><ArticleId IdType="pmc">PMC10143911</ArticleId><ArticleId IdType="pubmed">37112866</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornig M., Montoya J.G., Klimas N.G., Levine S., Felsenstein D., Bateman L., Peterson D.L., Gottschalk C.G., Schultz A.F., Che X., et al. Distinct plasma immune signatures in ME/CFS are present early in the course of illness. Sci. Adv. 2015;1:e1400121. doi: 10.1126/sciadv.1400121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.1400121</ArticleId><ArticleId IdType="pmc">PMC4465185</ArticleId><ArticleId IdType="pubmed">26079000</ArticleId></ArticleIdList></Reference><Reference><Citation>Glynne P., Tahmasebi N., Gant V., Gupta R. Long COVID following mild SARS-CoV-2 infection: Characteristic T cell alterations and response to antihistamines. J. Investig. Med. 2022;70:61&#x2013;67. doi: 10.1136/jim-2021-002051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jim-2021-002051</ArticleId><ArticleId IdType="pmc">PMC8494538</ArticleId><ArticleId IdType="pubmed">34611034</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung C.C.L., Goh D., Lim X., Tien T.Z., Lim J.C.T., Lee J.N., Tan B., Tay Z.E.A., Wan W.Y., Chen E.X., et al. Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19. Gut. 2022;71:226&#x2013;229. doi: 10.1136/gutjnl-2021-324280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-324280</ArticleId><ArticleId IdType="pubmed">34083386</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C., Wang Z., Lorenzi J.C.C., Muecksch F., Finkin S., Tokuyama M., Cho A., Jankovic M., Schaefer-Babajew D., Oliveira T.Y., et al. Evolution of antibody immunity to SARS-CoV-2. Nature. 2021;591:639&#x2013;644. doi: 10.1038/s41586-021-03207-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03207-w</ArticleId><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigal G.B., Novak T., Mathew A., Chou J., Zhang Y., Manjula N., Bathala P., Joe J., Padmanabhan N., Romero D., et al. Measurement of Severe Acute Respiratory Syndrome Coronavirus 2 Antigens in Plasma of Pediatric Patients with Acute Coronavirus Disease 2019 or Multisystem Inflammatory Syndrome in Children Using an Ultrasensitive and Quantitative Immunoassay. Clin. Infect. Dis. 2022;75:1351&#x2013;1358. doi: 10.1093/cid/ciac160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac160</ArticleId><ArticleId IdType="pmc">PMC8903440</ArticleId><ArticleId IdType="pubmed">35213684</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C., Zhao H., Esp&#xed;n E., Tebbutt S.J. Association of SARS-CoV-2 infection and persistence with long COVID. Lancet. Respir. Med. 2023;11:504&#x2013;506. doi: 10.1016/S2213-2600(23)00142-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(23)00142-X</ArticleId><ArticleId IdType="pmc">PMC10171832</ArticleId><ArticleId IdType="pubmed">37178694</ArticleId></ArticleIdList></Reference><Reference><Citation>Barouch D.H. COVID-19 Vaccines&#x2014;Immunity, Variants, Boosters. New Engl. J. Med. 2022;387:1011&#x2013;1020. doi: 10.1056/NEJMra2206573.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra2206573</ArticleId><ArticleId IdType="pmc">PMC9454645</ArticleId><ArticleId IdType="pubmed">36044620</ArticleId></ArticleIdList></Reference><Reference><Citation>Banko A., Miljanovic D., Cirkovic A. Systematic review with meta-analysis of active herpesvirus infections in patients with COVID-19: Old players on the new field. Int. J. Infect. Dis. 2023;130:108&#x2013;125. doi: 10.1016/j.ijid.2023.01.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2023.01.036</ArticleId><ArticleId IdType="pmc">PMC9889115</ArticleId><ArticleId IdType="pubmed">36736577</ArticleId></ArticleIdList></Reference><Reference><Citation>Manoharan S., Ying L.Y. Epstein Barr Virus Reactivation during COVID-19 Hospitalization Significantly Increased Mortality/Death in SARS-CoV-2(+)/EBV(+) than SARS-CoV-2(+)/EBV(&#x2212;) Patients: A Comparative Meta-Analysis. Int. J. Clin. Pract. 2023;2023:1068000. doi: 10.1155/2023/1068000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2023/1068000</ArticleId><ArticleId IdType="pmc">PMC9904914</ArticleId><ArticleId IdType="pubmed">36793928</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz-Pablos M., Paiva B., Montero-Mateo R., Garcia N., Zabaleta A. Epstein-Barr Virus and the Origin of Myalgic Encephalomyelitis or Chronic Fatigue Syndrome. Front. Immunol. 2021;12:656797. doi: 10.3389/fimmu.2021.656797.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.656797</ArticleId><ArticleId IdType="pmc">PMC8634673</ArticleId><ArticleId IdType="pubmed">34867935</ArticleId></ArticleIdList></Reference><Reference><Citation>Apostolou E., Rizwan M., Moustardas P., Sj&#xf6;gren P., Bertilson B.C., Brag&#xe9;e B., Polo O., Ros&#xe9;n A. Saliva antibody-fingerprint of reactivated latent viruses after mild/asymptomatic COVID-19 is unique in patients with myalgic-encephalomyelitis/chronic fatigue syndrome. Front. Immunol. 2022;13:949787. doi: 10.3389/fimmu.2022.949787.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.949787</ArticleId><ArticleId IdType="pmc">PMC9630598</ArticleId><ArticleId IdType="pubmed">36341457</ArticleId></ArticleIdList></Reference><Reference><Citation>Suurmond J., Diamond B. Autoantibodies in systemic autoimmune diseases: Specificity and pathogenicity. J. Clin. Investig. 2015;125:2194&#x2013;2202. doi: 10.1172/JCI78084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI78084</ArticleId><ArticleId IdType="pmc">PMC4497746</ArticleId><ArticleId IdType="pubmed">25938780</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight J.S., Caricchio R., Casanova J.L., Combes A.J., Diamond B., Fox S.E., Hanauer D.A., James J.A., Kanthi Y., Ladd V., et al. The intersection of COVID-19 and autoimmunity. J. Clin. Investig. 2021;131:e154886. doi: 10.1172/JCI154886.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI154886</ArticleId><ArticleId IdType="pmc">PMC8670833</ArticleId><ArticleId IdType="pubmed">34710063</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang E.Y., Mao T., Klein J., Dai Y., Huck J.D., Jaycox J.R., Liu F., Zhou T., Israelow B., Wong P., et al. Diverse functional autoantibodies in patients with COVID-19. Nature. 2021;595:283&#x2013;288. doi: 10.1038/s41586-021-03631-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03631-y</ArticleId><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard P., Gervais A., Le Voyer T., Rosain J., Philippot Q., Manry J., Michailidis E., Hoffmann H.H., Eto S., Garcia-Prat M., et al. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Sci. Immunol. 2021;6:eabl4340. doi: 10.1126/sciimmunol.abl4340.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abl4340</ArticleId><ArticleId IdType="pmc">PMC8521484</ArticleId><ArticleId IdType="pubmed">34413139</ArticleId></ArticleIdList></Reference><Reference><Citation>Manry J., Bastard P., Gervais A., Le Voyer T., Rosain J., Philippot Q., Michailidis E., Hoffmann H.H., Eto S., Garcia-Prat M., et al. The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies. Proc. Natl. Acad. Sci. USA. 2022;119:e2200413119. doi: 10.1073/pnas.2200413119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2200413119</ArticleId><ArticleId IdType="pmc">PMC9173764</ArticleId><ArticleId IdType="pubmed">35576468</ArticleId></ArticleIdList></Reference><Reference><Citation>Eto S., Nukui Y., Tsumura M., Nakagama Y., Kashimada K., Mizoguchi Y., Utsumi T., Taniguchi M., Sakura F., Noma K., et al. Neutralizing Type I Interferon Autoantibodies in Japanese Patients with Severe COVID-19. Res. Sq. 2022 doi: 10.1007/s10875-022-01308-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-022-01308-3</ArticleId><ArticleId IdType="pmc">PMC9243824</ArticleId><ArticleId IdType="pubmed">35764767</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q., Bastard P., Cobat A., Casanova J.L. Human genetic and immunological determinants of critical COVID-19 pneumonia. Nature. 2022;603:587&#x2013;598. doi: 10.1038/s41586-022-04447-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04447-0</ArticleId><ArticleId IdType="pmc">PMC8957595</ArticleId><ArticleId IdType="pubmed">35090163</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Thomas I.J., Munter S.E., Deeks S.G., Henrich T.J. Lack of Antinuclear Antibodies in Convalescent Coronavirus Disease 2019 Patients with Persistent Symptoms. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 2022;74:2083&#x2013;2084. doi: 10.1093/cid/ciab890.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab890</ArticleId><ArticleId IdType="pmc">PMC9187313</ArticleId><ArticleId IdType="pubmed">34617982</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthur J.M., Forrest J.C., Boehme K.W., Kennedy J.L., Owens S., Herzog C., Liu J., Harville T.O. Development of ACE2 autoantibodies after SARS-CoV-2 infection. PLoS ONE. 2021;16:e0257016. doi: 10.1371/journal.pone.0257016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0257016</ArticleId><ArticleId IdType="pmc">PMC8415618</ArticleId><ArticleId IdType="pubmed">34478478</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty H., Townsend L., Morrin H., Ahmad A., Comerford C., Karampini E., Englert H., Byrne M., Bergin C., O&#x2019;Sullivan J.M., et al. Persistent endotheliopathy in the pathogenesis of long COVID syndrome. J. Thromb. Haemost. JTH. 2021;19:2546&#x2013;2553. doi: 10.1111/jth.15490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15490</ArticleId><ArticleId IdType="pmc">PMC8420256</ArticleId><ArticleId IdType="pubmed">34375505</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarrott B., Head R., Pringle K.G., Lumbers E.R., Martin J.H. &#x201c;LONG COVID&#x201d;-A hypothesis for understanding the biological basis and pharmacological treatment strategy. Pharmacol. Res. Perspect. 2022;10:e00911. doi: 10.1002/prp2.911.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prp2.911</ArticleId><ArticleId IdType="pmc">PMC8929332</ArticleId><ArticleId IdType="pubmed">35029046</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan B.E., Wong S.W., Sum C.L.L., Lim G.H., Leung B.P., Tan C.W., Ramanathan K., Dalan R., Cheung C., Lim X.R., et al. Hypercoagulability, endotheliopathy, and inflammation approximating 1&#x2009;year after recovery: Assessing the long-term outcomes in COVID-19 patients. Am. J. Hematol. 2022;97:915&#x2013;923. doi: 10.1002/ajh.26575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.26575</ArticleId><ArticleId IdType="pmc">PMC9073976</ArticleId><ArticleId IdType="pubmed">35477923</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell D.B., Pretorius E. The potential role of ischaemia-reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: Evidence, mechanisms, and therapeutic implications. Biochem. J. 2022;479:1653&#x2013;1708. doi: 10.1042/BCJ20220154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BCJ20220154</ArticleId><ArticleId IdType="pmc">PMC9484810</ArticleId><ArticleId IdType="pubmed">36043493</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Venter C., Laubscher G.J., Kotze M.J., Oladejo S.O., Watson L.R., Rajaratnam K., Watson B.W., Kell D.B. Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/Post-Acute Sequelae of COVID-19 (PASC) Cardiovasc. Diabetol. 2022;21:148. doi: 10.1186/s12933-022-01579-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-022-01579-5</ArticleId><ArticleId IdType="pmc">PMC9356426</ArticleId><ArticleId IdType="pubmed">35933347</ArticleId></ArticleIdList></Reference><Reference><Citation>Du W.N., Zhang Y., Yu Y., Zhang R.M. D-dimer levels is associated with severe COVID-19 infections: A meta-analysis. Int. J. Clin. Pract. 2021;75:e14031. doi: 10.1111/ijcp.14031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.14031</ArticleId><ArticleId IdType="pmc">PMC7995215</ArticleId><ArticleId IdType="pubmed">33474792</ArticleId></ArticleIdList></Reference><Reference><Citation>Rushworth R.L., Torpy D.J., Falhammar H. Adrenal Crisis. New Engl. J. Med. 2019;381:852&#x2013;861. doi: 10.1056/NEJMra1807486.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1807486</ArticleId><ArticleId IdType="pubmed">31461595</ArticleId></ArticleIdList></Reference><Reference><Citation>Demitrack M.A., Dale J.K., Straus S.E., Laue L., Listwak S.J., Kruesi M.J., Chrousos G.P., Gold P.W. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J. Clin. Endocrinol. Metab. 1991;73:1224&#x2013;1234. doi: 10.1210/jcem-73-6-1224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jcem-73-6-1224</ArticleId><ArticleId IdType="pubmed">1659582</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y.J., Ko Y.C., Chow L.H., Hsiao F.J., Liu H.Y., Wang P.N., Chen W.T. Salivary cortisol is associated with cognitive changes in patients with fibromyalgia. Sci. Rep. 2021;11:1311. doi: 10.1038/s41598-020-79349-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-79349-0</ArticleId><ArticleId IdType="pmc">PMC7809444</ArticleId><ArticleId IdType="pubmed">33446677</ArticleId></ArticleIdList></Reference><Reference><Citation>Leow M.K., Kwek D.S., Ng A.W., Ong K.C., Kaw G.J., Lee L.S. Hypocortisolism in survivors of severe acute respiratory syndrome (SARS) Clin. Endocrinol. 2005;63:197&#x2013;202. doi: 10.1111/j.1365-2265.2005.02325.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2265.2005.02325.x</ArticleId><ArticleId IdType="pmc">PMC7188349</ArticleId><ArticleId IdType="pubmed">16060914</ArticleId></ArticleIdList></Reference><Reference><Citation>Choy K.W. Cortisol concentrations and mortality from COVID-19. Lancet. Diabetes Endocrinol. 2020;8:808. doi: 10.1016/S2213-8587(20)30305-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(20)30305-3</ArticleId><ArticleId IdType="pmc">PMC7492026</ArticleId><ArticleId IdType="pubmed">32946816</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedor C., Freitag H., Meyer-Arndt L., Wittke K., Hanitsch L.G., Zoller T., Steinbeis F., Haffke M., Rudolf G., Heidecker B., et al. A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity. Nat. Commun. 2022;13:5104. doi: 10.1038/s41467-022-32507-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-32507-6</ArticleId><ArticleId IdType="pmc">PMC9426365</ArticleId><ArticleId IdType="pubmed">36042189</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonilla H., Quach T.C., Tiwari A., Bonilla A.E., Miglis M., Yang P.C., Eggert L.E., Sharifi H., Horomanski A., Subramanian A., et al. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome is common in post-acute sequelae of SARS-CoV-2 infection (PASC): Results from a post-COVID-19 multidisciplinary clinic. Front. Neurol. 2023;14:1090747. doi: 10.3389/fneur.2023.1090747.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2023.1090747</ArticleId><ArticleId IdType="pmc">PMC9998690</ArticleId><ArticleId IdType="pubmed">36908615</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalamaga M., Christodoulatos G.S. Adiponectin as a biomarker linking obesity and adiposopathy to hematologic malignancies. Horm. Mol. Biol. Clin. Investig. 2015;23:5&#x2013;20. doi: 10.1515/hmbci-2015-0016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/hmbci-2015-0016</ArticleId><ArticleId IdType="pubmed">26057219</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalamaga M., Karmaniolas K., Chamberland J., Nikolaidou A., Lekka A., Dionyssiou-Asteriou A., Mantzoros C.S. Higher fetuin-A, lower adiponectin and free leptin levels mediate effects of excess body weight on insulin resistance and risk for myelodysplastic syndrome. Metabolism. 2013;62:1830&#x2013;1839. doi: 10.1016/j.metabol.2013.09.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2013.09.007</ArticleId><ArticleId IdType="pubmed">24140093</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalamaga M., Crotty B.H., Fargnoli J., Papadavid E., Lekka A., Triantafilli M., Karmaniolas K., Migdalis I., Dionyssiou-Asteriou A., Mantzoros C.S. B-cell chronic lymphocytic leukemia risk in association with serum leptin and adiponectin: A case-control study in Greece. Cancer Causes Control. CCC. 2010;21:1451&#x2013;1459. doi: 10.1007/s10552-010-9573-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10552-010-9573-y</ArticleId><ArticleId IdType="pmc">PMC3100743</ArticleId><ArticleId IdType="pubmed">20454844</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalamaga M., Karmaniolas K., Nikolaidou A., Chamberland J., Hsi A., Dionyssiou-Asteriou A., Mantzoros C.S. Adiponectin and resistin are associated with risk for myelodysplastic syndrome, independently from the insulin-like growth factor-I (IGF-I) system. Eur. J. Cancer. 2008;44:1744&#x2013;1753. doi: 10.1016/j.ejca.2008.04.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejca.2008.04.015</ArticleId><ArticleId IdType="pubmed">18515085</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalamaga M., Nikolaidou A., Karmaniolas K., Hsi A., Chamberland J., Dionyssiou-Asteriou A., Mantzoros C.S. Circulating adiponectin and leptin in relation to myelodysplastic syndrome: A case-control study. Oncology. 2007;73:26&#x2013;32. doi: 10.1159/000120995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000120995</ArticleId><ArticleId IdType="pubmed">18337619</ArticleId></ArticleIdList></Reference><Reference><Citation>Marouga A., Dalamaga M., Kastania A.N., Antonakos G., Thrasyvoulides A., Kontelia G., Dimas C., Vlahakos D.V. Correlates of serum resistin in elderly, non-diabetic patients with chronic kidney disease. Clin. Lab. 2013;59:1121&#x2013;1128. doi: 10.7754/Clin.Lab.2012.121112.</Citation><ArticleIdList><ArticleId IdType="doi">10.7754/Clin.Lab.2012.121112</ArticleId><ArticleId IdType="pubmed">24273936</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadavid E., Gazi S., Dalamaga M., Stavrianeas N., Ntelis V. Palmoplantar and scalp psoriasis occurring during anti-tumour necrosis factor-alpha therapy: A case series of four patients and guidelines for management. J. Eur. Acad. Dermatol. Venereol. 2008;22:380&#x2013;382. doi: 10.1111/j.1468-3083.2007.02335.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-3083.2007.02335.x</ArticleId><ArticleId IdType="pubmed">18269613</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadavid E., Vlami K., Dalamaga M., Giatrakou S., Theodoropoulos K., Gyftopoulos S., Stavrianeas N., Papiris S., Rigopoulos D. Sleep apnea as a comorbidity in obese psoriasis patients: A cross-sectional study. Do psoriasis characteristics and metabolic parameters play a role? J. Eur. Acad. Dermatol. Venereol. 2013;27:820&#x2013;826. doi: 10.1111/j.1468-3083.2012.04580.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-3083.2012.04580.x</ArticleId><ArticleId IdType="pubmed">22620285</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadavid E., Dalamaga M., Vlami K., Koumaki D., Gyftopoulos S., Christodoulatos G.S., Papiris S., Rigopoulos D. Psoriasis is associated with risk of obstructive sleep apnea independently from metabolic parameters and other comorbidities: A large hospital-based case-control study. Sleep Breath. Schlaf Atm. 2017;21:949&#x2013;958. doi: 10.1007/s11325-017-1507-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11325-017-1507-4</ArticleId><ArticleId IdType="pubmed">28484896</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavlidou A., Dalamaga M., Kroupis C., Konstantoudakis G., Belimezi M., Athanasas G., Dimas K. Survivin isoforms and clinicopathological characteristics in colorectal adenocarcinomas using real-time qPCR. World J. Gastroenterol. 2011;17:1614&#x2013;1621. doi: 10.3748/wjg.v17.i12.1614.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v17.i12.1614</ArticleId><ArticleId IdType="pmc">PMC3070134</ArticleId><ArticleId IdType="pubmed">21472129</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalamaga M., Karmaniolas K., Lekka A., Antonakos G., Thrasyvoulides A., Papadavid E., Spanos N., Dionyssiou-Asteriou A. Platelet markers correlate with glycemic indices in diabetic, but not diabetic-myelodysplastic patients with normal platelet count. Dis. Mrk. 2010;29:55&#x2013;61. doi: 10.1155/2010/284041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2010/284041</ArticleId><ArticleId IdType="pmc">PMC3835532</ArticleId><ArticleId IdType="pubmed">20826918</ArticleId></ArticleIdList></Reference><Reference><Citation>Bramante C.T., Buse J.B., Liebovitz D., Nicklas J., Puskarich M.A., Cohen K., Belani H., Anderson B., Huling J.D., Tignanelli C., et al. Outpatient treatment of COVID-19 with metformin, ivermectin, and fluvoxamine and the development of Long COVID over 10-month follow-up. medRxiv. 2022 doi: 10.1101/2022.12.21.22283753.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.12.21.22283753</ArticleId></ArticleIdList></Reference><Reference><Citation>Dissanayake H.A., de Silva N.L., Sumanatilleke M., de Silva S.D.N., Gamage K.K.K., Dematapitiya C., Kuruppu D.C., Ranasinghe P., Pathmanathan S., Katulanda P. Prognostic and Therapeutic Role of Vitamin D in COVID-19: Systematic Review and Meta-analysis. J. Clin. Endocrinol. Metab. 2022;107:1484&#x2013;1502. doi: 10.1210/clinem/dgab892.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgab892</ArticleId><ArticleId IdType="pmc">PMC8689831</ArticleId><ArticleId IdType="pubmed">34894254</ArticleId></ArticleIdList></Reference><Reference><Citation>Akbar M.R., Wibowo A., Pranata R., Setiabudiawan B. Corrigendum: Low Serum 25-hydroxyvitamin D (Vitamin D) Level Is Associated with Susceptibility to COVID-19, Severity, and Mortality: A Systematic Review and Meta-Analysis. Front. Nutr. 2021;8:754539. doi: 10.3389/fnut.2021.754539.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2021.754539</ArticleId><ArticleId IdType="pmc">PMC8039288</ArticleId><ArticleId IdType="pubmed">33855042</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilezikian J.P., Bikle D., Hewison M., Lazaretti-Castro M., Formenti A.M., Gupta A., Madhavan M.V., Nair N., Babalyan V., Hutchings N., et al. MECHANISMS IN ENDOCRINOLOGY: Vitamin D and COVID-19. Eur. J. Endocrinol. 2020;183:R133&#x2013;r147. doi: 10.1530/EJE-20-0665.</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/EJE-20-0665</ArticleId><ArticleId IdType="pmc">PMC9494342</ArticleId><ArticleId IdType="pubmed">32755992</ArticleId></ArticleIdList></Reference><Reference><Citation>Moukayed M. A Narrative Review on the Potential Role of Vitamin D(3) in the Prevention, Protection, and Disease Mitigation of Acute and Long COVID-19. Curr. Nutr. Rep. 2023;12:215&#x2013;223. doi: 10.1007/s13668-023-00471-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13668-023-00471-2</ArticleId><ArticleId IdType="pmc">PMC10161182</ArticleId><ArticleId IdType="pubmed">37145350</ArticleId></ArticleIdList></Reference><Reference><Citation>Bader-Larsen K.S., Larson E.A., Dalamaga M., Magkos F. A Narrative Review of the Safety of Anti-COVID-19 Nutraceuticals for Patients with Cancer. Cancers. 2021;13:6094. doi: 10.3390/cancers13236094.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers13236094</ArticleId><ArticleId IdType="pmc">PMC8656592</ArticleId><ArticleId IdType="pubmed">34885202</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia M., Seelaender M., Sotiropoulos A., Coletti D., Lancha A.H., Jr. Vitamin D, muscle recovery, sarcopenia, cachexia, and muscle atrophy. Nutrition. 2019;60:66&#x2013;69. doi: 10.1016/j.nut.2018.09.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nut.2018.09.031</ArticleId><ArticleId IdType="pubmed">30529188</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xe1;ll Z., Sz&#xe9;kely O. Role of Vitamin D in Cognitive Dysfunction: New Molecular Concepts and Discrepancies between Animal and Human Findings. Nutrients. 2021;13:3672. doi: 10.3390/nu13113672.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13113672</ArticleId><ArticleId IdType="pmc">PMC8620681</ArticleId><ArticleId IdType="pubmed">34835929</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalamaga M., Muscogiuri G., Paganitsa G., Parvouleskou G., Syriou V., Karagkoynis P., Stratigou T., Vallianou N., Christodoulatos G.S., Karampela I., et al. Adherence to the Mediterranean diet is an independent predictor of circulating vitamin D levels in normal weight and non-smoker adults: An observational cross-sectional study. Int. J. Food Sci. Nutr. 2021;72:848&#x2013;860. doi: 10.1080/09637486.2021.1878488.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09637486.2021.1878488</ArticleId><ArticleId IdType="pubmed">33509003</ArticleId></ArticleIdList></Reference><Reference><Citation>Jolliffe D.A., Camargo C.A., Jr., Sluyter J.D., Aglipay M., Aloia J.F., Ganmaa D., Bergman P., Bischoff-Ferrari H.A., Borzutzky A., Damsgaard C.T., et al. Vitamin D supplementation to prevent acute respiratory infections: A systematic review and meta-analysis of aggregate data from randomised controlled trials. Lancet. Diabetes Endocrinol. 2021;9:276&#x2013;292. doi: 10.1016/S2213-8587(21)00051-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(21)00051-6</ArticleId><ArticleId IdType="pubmed">33798465</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirhosseini N., Rainsbury J., Kimball S.M. Vitamin D Supplementation, Serum 25(OH)D Concentrations and Cardiovascular Disease Risk Factors: A Systematic Review and Meta-Analysis. Front. Cardiovasc. Med. 2018;5:87. doi: 10.3389/fcvm.2018.00087.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2018.00087</ArticleId><ArticleId IdType="pmc">PMC6052909</ArticleId><ArticleId IdType="pubmed">30050908</ArticleId></ArticleIdList></Reference><Reference><Citation>Karampela I., Sakelliou A., Vallianou N., Christodoulatos G.S., Magkos F., Dalamaga M. Vitamin D and Obesity: Current Evidence and Controversies. Curr. Obes. Rep. 2021;10:162&#x2013;180. doi: 10.1007/s13679-021-00433-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13679-021-00433-1</ArticleId><ArticleId IdType="pubmed">33792853</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandes A.L., Sales L.P., Santos M.D., Caparbo V.F., Murai I.H., Pereira R.M.R. Persistent or new symptoms 1 year after a single high dose of vitamin D(3) in patients with moderate to severe COVID-19. Front. Nutr. 2022;9:979667. doi: 10.3389/fnut.2022.979667.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2022.979667</ArticleId><ArticleId IdType="pmc">PMC9513442</ArticleId><ArticleId IdType="pubmed">36176639</ArticleId></ArticleIdList></Reference><Reference><Citation>Galluzzo V., Ciciarello F., Tosato M., Zazzara M.B., Pais C., Savera G., Calvani R., Picca A., Marzetti E., Landi F. Association between vitamin D status and physical performance in COVID-19 survivors: Results from the Gemelli against COVID-19 post-acute care project. Mech. Ageing Dev. 2022;205:111684. doi: 10.1016/j.mad.2022.111684.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mad.2022.111684</ArticleId><ArticleId IdType="pmc">PMC9093083</ArticleId><ArticleId IdType="pubmed">35568146</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruzzone C., Conde R., Embade N., Mato J.M., Millet O. Metabolomics as a powerful tool for diagnostic, pronostic and drug intervention analysis in COVID-19. Front. Mol. Biosci. 2023;10:1111482. doi: 10.3389/fmolb.2023.1111482.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2023.1111482</ArticleId><ArticleId IdType="pmc">PMC9975567</ArticleId><ArticleId IdType="pubmed">36876049</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;nig R.S., Albrich W.C., Kahlert C.R., Bahr L.S., L&#xf6;ber U., Vernazza P., Scheibenbogen C., Forslund S.K. The Gut Microbiome in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS) Front. Immunol. 2021;12:628741. doi: 10.3389/fimmu.2021.628741.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.628741</ArticleId><ArticleId IdType="pmc">PMC8761622</ArticleId><ArticleId IdType="pubmed">35046929</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallianou N.G., Kounatidis D., Tsilingiris D., Panagopoulos F., Christodoulatos G.S., Evangelopoulos A., Karampela I., Dalamaga M. The Role of Next-Generation Probiotics in Obesity and Obesity-Associated Disorders: Current Knowledge and Future Perspectives. Int. J. Mol. Sci. 2023;24:6755. doi: 10.3390/ijms24076755.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24076755</ArticleId><ArticleId IdType="pmc">PMC10095285</ArticleId><ArticleId IdType="pubmed">37047729</ArticleId></ArticleIdList></Reference><Reference><Citation>Papavasileiou G., Tsilingiris D., Spyrou N., Vallianou N.G., Karampela I., Magkos F., Dalamaga M. Obesity and main urologic cancers: Current systematic evidence, novel biological mechanisms, perspectives and challenges. Semin. Cancer Biol. 2023;91:70&#x2013;98. doi: 10.1016/j.semcancer.2023.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcancer.2023.03.002</ArticleId><ArticleId IdType="pubmed">36893965</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeoh Y.K., Zuo T., Lui G.C., Zhang F., Liu Q., Li A.Y., Chung A.C., Cheung C.P., Tso E.Y., Fung K.S., et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. 2021;70:698&#x2013;706. doi: 10.1136/gutjnl-2020-323020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-323020</ArticleId><ArticleId IdType="pmc">PMC7804842</ArticleId><ArticleId IdType="pubmed">33431578</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F., Lau R.I., Liu Q., Su Q., Chan F.K.L., Ng S.C. Gut microbiota in COVID-19: Key microbial changes, potential mechanisms and clinical applications. Nat. Rev. Gastroenterol. Hepatol. 2023;20:323&#x2013;337. doi: 10.1038/s41575-022-00698-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41575-022-00698-4</ArticleId><ArticleId IdType="pmc">PMC9589856</ArticleId><ArticleId IdType="pubmed">36271144</ArticleId></ArticleIdList></Reference><Reference><Citation>de Almeida V.M., Engel D., Ricci M.F., Cruz C.S., Lopes I.S., Alves D.A., Auriol M.D., Magalh&#xe3;es J., Zuccoli G.S., Smith B.J., et al. Gut microbiota from patients with mild COVID-19 cause alterations in mice that resemble post-COVID syndrome. Res. Sq. 2022 doi: 10.21203/rs.3.rs-1756189/v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-1756189/v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalamaga M., Karmaniolas K., Arsenis G., Pantelaki M., Daskalopoulou K., Papadavid E., Migdalis I. Cedecea lapagei bacteremia following cement-related chemical burn injury. Burns. 2008;34:1205&#x2013;1207. doi: 10.1016/j.burns.2007.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.burns.2007.09.001</ArticleId><ArticleId IdType="pubmed">18467034</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadavid E., Dalamaga M., Kapniari I., Pantelidaki E., Papageorgiou S., Pappa V., Tsirigotis P., Dervenoulas I., Stavrianeas N., Rigopoulos D. Lobomycosis: A case from Southeastern Europe and review of the literature. J. Dermatol. Case Rep. 2012;6:65&#x2013;69. doi: 10.3315/jdcr.2012.1104.</Citation><ArticleIdList><ArticleId IdType="doi">10.3315/jdcr.2012.1104</ArticleId><ArticleId IdType="pmc">PMC3470791</ArticleId><ArticleId IdType="pubmed">23091581</ArticleId></ArticleIdList></Reference><Reference><Citation>Giron L.B., Peluso M.J., Ding J., Kenny G., Zilberstein N.F., Koshy J., Hong K.Y., Rasmussen H., Miller G.E., Bishehsari F., et al. Markers of fungal translocation are elevated during post-acute sequelae of SARS-CoV-2 and induce NF-&#x3ba;B signaling. JCI Insight. 2022;7:e160989. doi: 10.1172/jci.insight.160989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.160989</ArticleId><ArticleId IdType="pmc">PMC9462470</ArticleId><ArticleId IdType="pubmed">35727635</ArticleId></ArticleIdList></Reference><Reference><Citation>Domingues R.B., Leite F., Senne C. Cerebrospinal fluid analysis in patients with COVID-19-associated central nervous system manifestations: A systematic review. Arq. De Neuro-Psiquiatr. 2022;80:296&#x2013;305. doi: 10.1590/0004-282x-anp-2021-0117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/0004-282x-anp-2021-0117</ArticleId><ArticleId IdType="pmc">PMC9648929</ArticleId><ArticleId IdType="pubmed">35239818</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrin P., Collongues N., Baloglu S., Bedo D., Bassand X., Lavaux T., Gautier-Vargas G., Keller N., Kremer S., Fafi-Kremer S., et al. Cytokine release syndrome-associated encephalopathy in patients with COVID-19. Eur. J. Neurol. 2021;28:248&#x2013;258. doi: 10.1111/ene.14491.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14491</ArticleId><ArticleId IdType="pmc">PMC7461405</ArticleId><ArticleId IdType="pubmed">32853434</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaumont H., Kaczorowski F., San-Galli A., Michel P.P., Tressi&#xe8;res B., Roze E., Quadrio I., Lannuzel A. Cerebrospinal fluid biomarkers in SARS-CoV-2 patients with acute neurological syndromes. Rev. Neurol. 2023;179:208&#x2013;217. doi: 10.1016/j.neurol.2022.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurol.2022.11.002</ArticleId><ArticleId IdType="pmc">PMC9708608</ArticleId><ArticleId IdType="pubmed">36610823</ArticleId></ArticleIdList></Reference><Reference><Citation>Guillot F., Garcia A., Salou M., Brouard S., Laplaud D.A., Nicot A.B. Transcript analysis of laser capture microdissected white matter astrocytes and higher phenol sulfotransferase 1A1 expression during autoimmune neuroinflammation. J. Neuroinflammation. 2015;12:130. doi: 10.1186/s12974-015-0348-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-015-0348-y</ArticleId><ArticleId IdType="pmc">PMC4501186</ArticleId><ArticleId IdType="pubmed">26141738</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Sans H.M., Forman C.A., Nylander A.N., Ho H.E., Lu S., Goldberg S.A., Hoh R., Tai V., Munter S.E., et al. Plasma Markers of Neurologic Injury and Inflammation in People with Self-Reported Neurologic Postacute Sequelae of SARS-CoV-2 Infection. Neurol. (R) Neuroimmunol. Neuroinflamm. 2022;9:e200003. doi: 10.1212/NXI.0000000000200003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000200003</ArticleId><ArticleId IdType="pmc">PMC9210548</ArticleId><ArticleId IdType="pubmed">35701186</ArticleId></ArticleIdList></Reference><Reference><Citation>Magdy R., Eid R.A., Fathy W., Abdel-Aziz M.M., Ibrahim R.E., Yehia A., Sheemy M.S., Hussein M. Characteristics and Risk Factors of Persistent Neuropathic Pain in Recovered COVID-19 Patients. Pain Med. 2022;23:774&#x2013;781. doi: 10.1093/pm/pnab341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/pm/pnab341</ArticleId><ArticleId IdType="pmc">PMC8755258</ArticleId><ArticleId IdType="pubmed">34931670</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Deeks S.G., Mustapic M., Kapogiannis D., Henrich T.J., Lu S., Goldberg S.A., Hoh R., Chen J.Y., Martinez E.O., et al. SARS-CoV-2 and Mitochondrial Proteins in Neural-Derived Exosomes of COVID-19. Ann. Neurol. 2022;91:772&#x2013;781. doi: 10.1002/ana.26350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26350</ArticleId><ArticleId IdType="pmc">PMC9082480</ArticleId><ArticleId IdType="pubmed">35285072</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J., Tang L., Ma Y., Li Y., Zhang D., Li Q., Mei H., Hu Y. Immunological Profiling of COVID-19 Patients with Pulmonary Sequelae. mBio. 2021;12:e0159921. doi: 10.1128/mBio.01599-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.01599-21</ArticleId><ArticleId IdType="pmc">PMC8546863</ArticleId><ArticleId IdType="pubmed">34488453</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re&#x2019;em Y., Redfield S., Austin J.P., Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Apostolo D., D&#x2019;Onghia D., Tonello S., Minisini R., Baricich A., Gramaglia C., Patrucco F., Zeppegno P., Acquaviva A., Balbo P.E., et al. Decreased Gas6 and sAxl Plasma Levels Are Associated with Hair Loss in COVID-19 Survivors. Int. J. Mol. Sci. 2023;24:6257. doi: 10.3390/ijms24076257.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24076257</ArticleId><ArticleId IdType="pmc">PMC10094682</ArticleId><ArticleId IdType="pubmed">37047229</ArticleId></ArticleIdList></Reference><Reference><Citation>Haslam A., Olivier T., Prasad V. The definition of long COVID used in interventional studies. Eur. J. Clin. Investig. 2023:e13989. doi: 10.1111/eci.13989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.13989</ArticleId><ArticleId IdType="pubmed">36964995</ArticleId></ArticleIdList></Reference><Reference><Citation>Fawzy N.A., Abou Shaar B., Taha R.M., Arabi T.Z., Sabbah B.N., Alkodaymi M.S., Omrani O.A., Makhzoum T., Almahfoudh N.E., Al-Hammad Q.A., et al. A systematic review of trials currently investigating therapeutic modalities for post-acute COVID-19 syndrome and registered on WHO International Clinical Trials Platform. Clin. Microbiol. Infect. 2023;29:570&#x2013;577. doi: 10.1016/j.cmi.2023.01.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2023.01.007</ArticleId><ArticleId IdType="pmc">PMC9837206</ArticleId><ArticleId IdType="pubmed">36642173</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T., Sivan M., Delaney B., Evans R., Milne R. Long COVID-an update for primary care. BMJ. 2022;378:e072117. doi: 10.1136/bmj-2022-072117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-072117</ArticleId><ArticleId IdType="pubmed">36137612</ArticleId></ArticleIdList></Reference><Reference><Citation>Chadda K.R., Blakey E.E., Huang C.L., Jeevaratnam K. Long COVID-19 and Postural Orthostatic Tachycardia Syndrome&#x2014;Is Dysautonomia to Be Blamed? Front. Cardiovasc. Med. 2022;9:860198. doi: 10.3389/fcvm.2022.860198.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.860198</ArticleId><ArticleId IdType="pmc">PMC8959615</ArticleId><ArticleId IdType="pubmed">35355961</ArticleId></ArticleIdList></Reference><Reference><Citation>Geng L.N., Bonilla H.F., Shafer R.W., Miglis M.G., Yang P.C. The Use of Nirmatrelvir-ritonavir in a Case of Breakthrough Long COVID. Explor. Res. Hypothesis Med. 2023 doi: 10.14218/ERHM.2022.00045.</Citation><ArticleIdList><ArticleId IdType="doi">10.14218/ERHM.2022.00045</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Choi T., Al-Aly Z. Association of Treatment with Nirmatrelvir and the Risk of Post-COVID-19 Condition. JAMA Intern. Med. 2023;183:554&#x2013;564. doi: 10.1001/jamainternmed.2023.0743.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2023.0743</ArticleId><ArticleId IdType="pmc">PMC10037200</ArticleId><ArticleId IdType="pubmed">36951829</ArticleId></ArticleIdList></Reference><Reference><Citation>Bajema K.L., Berry K., Streja E., Rajeevan N., Li Y., Yan L., Cunningham F., Hynes D.M., Rowneki M., Bohnert A., et al. Effectiveness of COVID-19 treatment with nirmatrelvir-ritonavir or molnupiravir among U.S. Veterans: Target trial emulation studies with one-month and six-month outcomes. medRxiv. 2022 doi: 10.1101/2022.12.05.22283134.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.12.05.22283134</ArticleId><ArticleId IdType="pmc">PMC10243488</ArticleId><ArticleId IdType="pubmed">37276589</ArticleId></ArticleIdList></Reference><Reference><Citation>Durstenfeld M.S., Peluso M.J., Lin F., Peyser N.D., Isasi C., Carton T.W., Henrich T.J., Deeks S.G., Olgin J.E., Pletcher M.J., et al. Association of Nirmatrelvir/Ritonavir Treatment with Long COVID Symptoms in an Online Cohort of Non-Hospitalized Individuals Experiencing Breakthrough SARS-CoV-2 Infection in the Omicron Era. medRxiv. 2023 doi: 10.1101/2023.03.02.23286730.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.03.02.23286730</ArticleId></ArticleIdList></Reference><Reference><Citation>Parthasarathy H., Tandel D., Siddiqui A.H., Harshan K.H. Metformin suppresses SARS-CoV-2 in cell culture. Virus Res. 2022;323:199010. doi: 10.1016/j.virusres.2022.199010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2022.199010</ArticleId><ArticleId IdType="pmc">PMC9676078</ArticleId><ArticleId IdType="pubmed">36417940</ArticleId></ArticleIdList></Reference><Reference><Citation>Ventura-L&#xf3;pez C., Cervantes-Luevano K., Aguirre-S&#xe1;nchez J.S., Flores-Caballero J.C., Alvarez-Delgado C., Bernaldez-Sarabia J., S&#xe1;nchez-Campos N., Lugo-S&#xe1;nchez L.A., Rodr&#xed;guez-V&#xe1;zquez I.C., Sander-Padilla J.G., et al. Treatment with metformin glycinate reduces SARS-CoV-2 viral load: An in vitro model and randomized, double-blind, Phase IIb clinical trial. Biomed. Pharmacother. Biomed. Pharmacother. 2022;152:113223. doi: 10.1016/j.biopha.2022.113223.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2022.113223</ArticleId><ArticleId IdType="pmc">PMC9159967</ArticleId><ArticleId IdType="pubmed">35709650</ArticleId></ArticleIdList></Reference><Reference><Citation>Daou N., Viader A., Cokol M., Nitzel A., Chakravarthy M.V., Afeyan R., Tramontin T., Marukian S., Hamill M.J. A novel, multitargeted endogenous metabolic modulator composition impacts metabolism, inflammation, and fibrosis in nonalcoholic steatohepatitis-relevant primary human cell models. Sci. Rep. 2021;11:11861. doi: 10.1038/s41598-021-88913-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-88913-1</ArticleId><ArticleId IdType="pmc">PMC8178416</ArticleId><ArticleId IdType="pubmed">34088912</ArticleId></ArticleIdList></Reference><Reference><Citation>Finnigan L.E.M., Cassar M.P., Koziel M.J., Pradines J., Lamlum H., Azer K., Kirby D., Montgomery H., Neubauer S., Valkovi&#x10d; L., et al. Efficacy and tolerability of an endogenous metabolic modulator (AXA1125) in fatigue-predominant long COVID: A single-centre, double-blind, randomised controlled phase 2a pilot study. eClinicalMedicine. 2023;59:101946. doi: 10.1016/j.eclinm.2023.101946.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2023.101946</ArticleId><ArticleId IdType="pmc">PMC10102537</ArticleId><ArticleId IdType="pubmed">37223439</ArticleId></ArticleIdList></Reference><Reference><Citation> [(accessed on 15 May 2023)]; Available online:  https://clinicaltrials.gov/</Citation></Reference><Reference><Citation>Kritis P., Karampela I., Kokoris S., Dalamaga M. The combination of bromelain and curcumin as an immune-boosting nutraceutical in the prevention of severe COVID-19. Metab. Open. 2020;8:100066. doi: 10.1016/j.metop.2020.100066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metop.2020.100066</ArticleId><ArticleId IdType="pmc">PMC7661945</ArticleId><ArticleId IdType="pubmed">33205039</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>